| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.932 | 0.003 | 0.932 | Antioxidant | 0.829 0.004 DBMET00799 0.755 0.005 DBMET03074 0.254 0.082 DBMET03075 0.294 0.064 DBMET00552 0.196 0.116 DBMET03076 0.161 0.152 DBMET03077 | ||
| 0.903 | 0.001 | 0.903 | Peroxidase inhibitor | 0.773 0.002 DBMET00799 0.792 0.002 DBMET03074 0.499 0.01 DBMET03075 0.631 0.004 DBMET00552 0.472 0.012 DBMET03076 0.549 0.006 DBMET03077 | ||
| 0.854 | 0.009 | 0.854 | Antiinflammatory | 0.74 0.024 DBMET00799 0.44 0.115 DBMET03074 | ||
| 0.816 | 0.001 | 0.816 | Phenylalanine 4-hydroxylase inhibitor | 0.644 0.002 DBMET00799 0.644 0.002 DBMET03074 0.371 0.003 DBMET03075 0.383 0.003 DBMET00552 0.286 0.004 DBMET03076 0.371 0.003 DBMET03077 | ||
| 0.797 | 0.004 | 0.921 | Free radical scavenger | 0.639 0.007 DBMET00799 0.921 0.003 DBMET03074 0.16 0.134 DBMET03075 0.255 0.066 DBMET00552 | DBMET03074 | |
| 0.779 | 0.002 | 0.779 | Lipid peroxidase inhibitor | 0.687 0.003 DBMET00799 0.738 0.003 DBMET03074 0.145 0.072 DBMET00552 | ||
| 0.77 | 0.02 | 0.77 | Apoptosis agonist | 0.491 0.077 DBMET00799 0.572 0.055 DBMET03074 0.381 0.123 DBMET03075 | ||
| 0.752 | 0.009 | 0.908 | Cyclophilin D inhibitor | 0.637 0.021 DBMET00799 0.908 0.005 DBMET03074 0.448 0.068 DBMET03075 0.559 0.035 DBMET00552 0.639 0.021 DBMET03077 | DBMET03074 | |
| 0.727 | 0.018 | 0.727 | Transcription factor NF kappa B inhibitor | 0.573 0.035 DBMET00799 0.535 0.039 DBMET03074 0.311 0.089 DBMET00552 0.299 0.094 DBMET03076 0.209 0.16 DBMET03077 | ||
| 0.67 | 0.005 | 0.67 | Apoptosis antagonist | 0.478 0.023 DBMET00799 0.588 0.011 DBMET03074 0.326 0.069 DBMET03075 0.455 0.027 DBMET00552 0.504 0.02 DBMET03076 0.294 0.09 DBMET03077 | ||
| 0.634 | 0.007 | 0.664 | 5 Hydroxytryptamine release inhibitor | 0.322 0.141 DBMET00799 0.664 0.005 DBMET03074 0.525 0.025 DBMET03075 0.608 0.01 DBMET00552 0.512 0.029 DBMET03076 0.581 0.014 DBMET03077 | DBMET03074 | |
| 0.608 | 0.005 | 0.608 | Vasodilator | 0.312 0.044 DBMET00799 0.511 0.011 DBMET03074 0.175 0.126 DBMET03075 0.221 0.089 DBMET03076 | ||
| 0.598 | 0.005 | 0.598 | Monophenol monooxygenase inhibitor | 0.414 0.011 DBMET00799 0.311 0.017 DBMET03074 0.09 0.084 DBMET03075 0.158 0.044 DBMET00552 0.111 0.068 DBMET03076 0.119 0.062 DBMET03077 | ||
| 0.6 | 0.011 | 0.6 | Immunomodulator | 0.445 0.032 DBMET00799 0.471 0.028 DBMET03074 | ||
| 0.574 | 0.003 | 0.574 | Cyclooxygenase 3 inhibitor | 0.202 0.018 DBMET00799 0.389 0.004 DBMET03074 0.133 0.064 DBMET03075 0.212 0.015 DBMET00552 0.107 0.093 DBMET03076 0.14 0.057 DBMET03077 | ||
| 0.572 | 0.004 | 0.572 | 5-Lipoxygenase inhibitor | 0.111 0.056 DBMET00799 0.528 0.004 DBMET03074 0.116 0.052 DBMET00552 | ||
| 0.573 | 0.024 | 0.644 | Antibacterial | 0.644 0.014 DBMET00799 0.511 0.037 DBMET03074 0.435 0.062 DBMET03075 0.413 0.071 DBMET00552 0.435 0.062 DBMET03076 0.355 0.099 DBMET03077 | DBMET00799 | |
| 0.556 | 0.009 | 0.93 | Platelet antagonist | 0.352 0.038 DBMET00799 0.238 0.078 DBMET03074 0.93 0.003 DBMET00552 | DBMET00552 | |
| 0.56 | 0.021 | 0.603 | Immunostimulant | 0.603 0.016 DBMET00799 0.499 0.029 DBMET03074 0.401 0.049 DBMET03075 0.329 0.071 DBMET00552 0.374 0.057 DBMET03076 0.314 0.075 DBMET03077 | DBMET00799 | |
| 0.532 | 0.006 | 0.75 | Diuretic | 0.75 0.003 DBMET00799 0.296 0.023 DBMET03074 0.151 0.077 DBMET03075 0.212 0.04 DBMET00552 0.123 0.101 DBMET03077 | DBMET00799 | |
| 0.524 | 0.005 | 0.897 | Alpha-N-acetylglucosaminidase inhibitor | 0.186 0.038 DBMET00799 0.497 0.005 DBMET03074 0.874 0.001 DBMET03075 0.856 0.002 DBMET00552 0.897 0.001 DBMET03076 0.831 0.002 DBMET03077 | DBMET03076 | |
| 0.518 | 0.005 | 0.521 | Thrombolytic | 0.521 0.005 DBMET00799 0.429 0.009 DBMET03074 0.413 0.01 DBMET00552 | DBMET00799 | |
| 0.537 | 0.024 | 0.549 | Immunosuppressant | 0.47 0.041 DBMET00799 0.549 0.021 DBMET03074 0.429 0.053 DBMET03075 0.318 0.104 DBMET00552 0.383 0.07 DBMET03076 0.305 0.112 DBMET03077 | DBMET03074 | |
| 0.519 | 0.011 | 0.555 | Hypolipemic | 0.319 0.043 DBMET00799 0.555 0.009 DBMET03074 0.35 0.035 DBMET03075 0.413 0.023 DBMET00552 0.316 0.044 DBMET03077 | DBMET03074 | |
| 0.505 | 0.002 | 0.514 | Catalase inhibitor | 0.514 0.002 DBMET00799 0.426 0.003 DBMET03074 0.337 0.005 DBMET03075 0.377 0.004 DBMET00552 0.369 0.004 DBMET03076 0.264 0.008 DBMET03077 | DBMET00799 | |
| 0.498 | 0.004 | 0.498 | Insulin sensitizer | 0.293 0.017 DBMET00799 0.347 0.009 DBMET03074 0.235 0.044 DBMET03075 0.27 0.024 DBMET00552 0.186 0.088 DBMET03076 0.208 0.066 DBMET03077 | ||
| 0.488 | 0.004 | 0.488 | Mediator release inhibitor | 0.194 0.016 DBMET03074 0.144 0.031 DBMET03075 0.126 0.042 DBMET00552 0.108 0.06 DBMET03077 | ||
| 0.501 | 0.019 | 0.501 | Lipoxygenase inhibitor | 0.199 0.141 DBMET00799 0.335 0.056 DBMET03074 0.218 0.123 DBMET00552 | ||
| 0.514 | 0.034 | 0.839 | Antiobesity | 0.545 0.029 DBMET00799 0.839 0.005 DBMET03074 0.295 0.12 DBMET03077 | DBMET03074 | |
| 0.481 | 0.004 | 0.481 | Neurotrophic factor enhancer | 0.225 0.055 DBMET00799 0.357 0.008 DBMET03074 0.193 0.084 DBMET03075 0.283 0.023 DBMET00552 0.209 0.069 DBMET03076 0.236 0.047 DBMET03077 | ||
| 0.485 | 0.034 | 0.495 | Calcium channel L-type activator | 0.271 0.184 DBMET00799 0.495 0.03 DBMET03074 0.44 0.056 DBMET00552 | DBMET03074 | |
| 0.453 | 0.009 | 0.453 | Non-steroidal antiinflammatory agent | 0.214 0.061 DBMET00799 0.244 0.045 DBMET03074 0.161 0.102 DBMET03075 0.261 0.039 DBMET00552 0.229 0.052 DBMET03076 0.156 0.107 DBMET03077 | ||
| 0.438 | 0.006 | 0.642 | Hemostatic | 0.642 0.003 DBMET00799 0.242 0.023 DBMET03074 0.168 0.05 DBMET00552 | DBMET00799 | |
| 0.467 | 0.037 | 0.791 | Aldehyde oxidase inhibitor | 0.442 0.041 DBMET03074 0.724 0.007 DBMET03075 0.748 0.005 DBMET00552 0.769 0.005 DBMET03076 0.791 0.004 DBMET03077 | DBMET03077 | |
| 0.414 | 0.004 | 0.482 | Cholesterol synthesis inhibitor | 0.482 0.003 DBMET00799 0.404 0.004 DBMET03074 0.181 0.032 DBMET03075 0.252 0.017 DBMET00552 0.245 0.018 DBMET03076 0.189 0.029 DBMET03077 | DBMET00799 | |
| 0.391 | 0.002 | 0.391 | Maillard reaction inhibitor | 0.24 0.004 DBMET00799 0.289 0.003 DBMET03074 0.077 0.026 DBMET03075 0.104 0.015 DBMET00552 | ||
| 0.462 | 0.077 | 0.604 | Caspase 9 stimulant | 0.465 0.075 DBMET03074 0.495 0.062 DBMET03075 0.59 0.037 DBMET00552 0.547 0.045 DBMET03076 0.604 0.035 DBMET03077 | DBMET03077 | |
| 0.429 | 0.044 | 0.616 | Cholesterol antagonist | 0.616 0.017 DBMET00799 0.394 0.051 DBMET03074 0.545 0.026 DBMET03075 0.591 0.02 DBMET00552 0.51 0.031 DBMET03076 0.564 0.023 DBMET03077 | DBMET00799 | |
| 0.388 | 0.004 | 0.388 | AMP-activated protein kinase stimulant | 0.171 0.017 DBMET03074 0.142 0.033 DBMET00552 | ||
| 0.398 | 0.022 | 0.441 | DNA synthesis inhibitor | 0.309 0.041 DBMET00799 0.404 0.021 DBMET03074 0.378 0.025 DBMET03075 0.39 0.023 DBMET00552 0.441 0.018 DBMET03076 0.37 0.026 DBMET03077 | DBMET03076 | |
| 0.385 | 0.008 | 0.385 | Peptidyltransferase inhibitor | 0.299 0.025 DBMET00799 0.384 0.008 DBMET03074 0.272 0.037 DBMET03075 0.342 0.013 DBMET00552 0.274 0.036 DBMET03076 0.29 0.028 DBMET03077 | ||
| 0.377 | 0.005 | 0.377 | Xanthine oxidase inhibitor | 0.129 0.043 DBMET00799 0.211 0.017 DBMET03074 0.16 0.031 DBMET00552 | ||
| 0.368 | 0.009 | 0.368 | Cyclooxygenase 1 inhibitor | 0.231 0.025 DBMET00799 0.245 0.022 DBMET03074 0.121 0.079 DBMET00552 | ||
| 0.419 | 0.066 | 0.543 | Histamine release inhibitor | 0.401 0.075 DBMET00799 0.43 0.06 DBMET03074 0.471 0.04 DBMET03075 0.543 0.017 DBMET00552 0.458 0.046 DBMET03076 0.502 0.028 DBMET03077 | DBMET00552 | |
| 0.375 | 0.035 | 0.493 | Interleukin 2 agonist | 0.254 0.114 DBMET00799 0.371 0.037 DBMET03074 0.315 0.064 DBMET03075 0.493 0.009 DBMET00552 0.241 0.129 DBMET03076 0.291 0.081 DBMET03077 | DBMET00552 | |
| 0.399 | 0.06 | 0.399 | Toll-Like receptor agonist | |||
| 0.34 | 0.021 | 0.723 | Hepatoprotectant | 0.333 0.022 DBMET00799 0.235 0.048 DBMET03074 0.432 0.011 DBMET03075 0.29 0.033 DBMET00552 0.246 0.044 DBMET03076 0.723 0.004 DBMET03077 | DBMET03077 | |
| 0.371 | 0.057 | 0.581 | Antithrombotic | 0.581 0.018 DBMET00799 0.364 0.06 DBMET03074 0.3 0.088 DBMET03075 0.402 0.049 DBMET00552 0.417 0.045 DBMET03076 0.309 0.082 DBMET03077 | DBMET00799 | |
| 0.302 | 0.005 | 0.364 | Electron transport complex I inhibitor | 0.136 0.03 DBMET00799 0.364 0.004 DBMET03074 0.113 0.057 DBMET03077 | DBMET03074 | |
| 0.291 | 0.005 | 0.312 | Aldose reductase inhibitor | 0.209 0.007 DBMET00799 0.113 0.015 DBMET03074 0.312 0.004 DBMET00552 | DBMET00552 | |
| 0.32 | 0.034 | 0.32 | Cyclic AMP phosphodiesterase inhibitor | 0.315 0.036 DBMET03074 0.169 0.124 DBMET03075 0.287 0.047 DBMET00552 0.194 0.099 DBMET03076 0.264 0.057 DBMET03077 | ||
| 0.283 | 0.011 | 0.529 | UDP-glucose 4-epimerase inhibitor | 0.094 0.068 DBMET00799 0.277 0.011 DBMET03074 0.454 0.004 DBMET03075 0.392 0.006 DBMET00552 0.529 0.002 DBMET03076 0.476 0.003 DBMET03077 | DBMET03076 | |
| 0.283 | 0.019 | 0.283 | Protein kinase stimulant | 0.282 0.019 DBMET03074 0.18 0.05 DBMET03075 0.255 0.025 DBMET00552 0.178 0.051 DBMET03076 0.217 0.036 DBMET03077 | ||
| 0.28 | 0.017 | 0.311 | Nitric-oxide synthase stimulant | 0.269 0.022 DBMET03074 0.223 0.056 DBMET03075 0.311 0.009 DBMET00552 0.24 0.04 DBMET03076 0.271 0.021 DBMET03077 | DBMET00552 | |
| 0.276 | 0.021 | 0.276 | Cyclooxygenase inhibitor | 0.142 0.077 DBMET00799 0.181 0.05 DBMET03074 | ||
| 0.27 | 0.017 | 0.598 | Succinate dehydrogenase inhibitor | 0.2 0.049 DBMET00799 0.267 0.017 DBMET03074 0.532 0.003 DBMET03075 0.566 0.003 DBMET00552 0.598 0.002 DBMET03076 0.421 0.004 DBMET03077 | DBMET03076 | |
| 0.268 | 0.019 | 0.268 | Phospholipase A2 inhibitor | 0.242 0.025 DBMET00799 0.207 0.039 DBMET03074 0.159 0.066 DBMET03075 0.213 0.036 DBMET00552 0.204 0.04 DBMET03076 0.168 0.06 DBMET03077 | ||
| 0.279 | 0.031 | 0.345 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.275 0.032 DBMET03074 0.214 0.062 DBMET03075 0.345 0.013 DBMET00552 0.215 0.061 DBMET03076 0.262 0.037 DBMET03077 | DBMET00552 | |
| 0.309 | 0.071 | 0.457 | Sodium/bile acid cotransporter inhibitor | 0.306 0.073 DBMET00799 0.259 0.119 DBMET03074 0.339 0.047 DBMET03075 0.457 0.007 DBMET00552 0.229 0.152 DBMET03076 0.297 0.082 DBMET03077 | DBMET00552 | |
| 0.24 | 0.004 | 0.24 | Phosphorylase inhibitor | 0.153 0.007 DBMET00799 0.116 0.011 DBMET03074 0.089 0.015 DBMET03075 0.078 0.017 DBMET00552 0.085 0.015 DBMET03076 0.051 0.03 DBMET03077 | ||
| 0.242 | 0.007 | 0.705 | Triose-phosphate isomerase inhibitor | 0.518 0.002 DBMET00799 0.294 0.005 DBMET03074 0.705 0.001 DBMET03075 0.528 0.002 DBMET00552 0.691 0.001 DBMET03076 0.652 0.001 DBMET03077 | DBMET03075 | |
| 0.243 | 0.008 | 0.475 | Phosphofructokinase-1 inhibitor | 0.161 0.016 DBMET00799 0.231 0.009 DBMET03074 0.475 0.002 DBMET03075 0.365 0.004 DBMET00552 0.437 0.003 DBMET03076 0.344 0.004 DBMET03077 | DBMET03075 | |
| 0.261 | 0.026 | 0.28 | Interferon gamma antagonist | 0.261 0.026 DBMET03074 0.169 0.058 DBMET03075 0.28 0.023 DBMET00552 0.174 0.054 DBMET03076 0.191 0.044 DBMET03077 | DBMET00552 | |
| 0.326 | 0.095 | 0.326 | Toll-Like receptor 7 agonist | |||
| 0.286 | 0.055 | 0.402 | Interleukin agonist | 0.297 0.05 DBMET03074 0.255 0.075 DBMET03075 0.402 0.018 DBMET00552 0.223 0.1 DBMET03076 0.279 0.059 DBMET03077 | DBMET00552 | |
| 0.267 | 0.043 | 0.415 | Anesthetic general | 0.25 0.05 DBMET03074 0.248 0.051 DBMET03075 0.415 0.015 DBMET00552 0.26 0.046 DBMET03076 0.308 0.031 DBMET03077 | DBMET00552 | |
| 0.222 | 0.003 | 0.312 | Mannosidase inhibitor | 0.312 0.002 DBMET00799 0.202 0.003 DBMET03074 0.166 0.004 DBMET03075 0.136 0.004 DBMET00552 0.231 0.003 DBMET03076 0.151 0.004 DBMET03077 | DBMET00799 | |
| 0.267 | 0.053 | 0.571 | Tyrosine 3 hydroxylase inhibitor | 0.248 0.069 DBMET03074 0.28 0.044 DBMET03075 0.571 0.003 DBMET00552 0.245 0.073 DBMET03076 0.281 0.043 DBMET03077 | DBMET00552 | |
| 0.22 | 0.008 | 0.231 | Transcription factor NF kappa B stimulant | 0.122 0.024 DBMET00799 0.231 0.007 DBMET03074 0.104 0.035 DBMET00552 | DBMET03074 | |
| 0.217 | 0.005 | 0.217 | Adrenaline agonist | 0.091 0.044 DBMET03074 0.083 0.053 DBMET00552 | ||
| 0.239 | 0.031 | 0.531 | Amylase inhibitor | 0.21 0.041 DBMET03074 0.412 0.009 DBMET03075 0.324 0.015 DBMET00552 0.531 0.005 DBMET03076 0.378 0.011 DBMET03077 | DBMET03076 | |
| 0.208 | 0.005 | 0.208 | Interferon agonist | 0.142 0.011 DBMET00799 0.119 0.018 DBMET03074 0.113 0.02 DBMET03075 0.123 0.016 DBMET00552 0.129 0.014 DBMET03076 0.117 0.019 DBMET03077 | ||
| 0.218 | 0.018 | 0.238 | Antineoplastic antibiotic | 0.195 0.022 DBMET00799 0.222 0.018 DBMET03074 0.238 0.015 DBMET03075 0.093 0.05 DBMET03076 | DBMET03075 | |
| 0.203 | 0.005 | 0.203 | Androgen agonist | 0.17 0.006 DBMET00799 0.131 0.009 DBMET03074 0.085 0.021 DBMET00552 | ||
| 0.227 | 0.033 | 0.312 | Melanin inhibitor | 0.206 0.038 DBMET03074 0.185 0.048 DBMET03075 0.217 0.035 DBMET00552 0.312 0.02 DBMET03076 0.219 0.035 DBMET03077 | DBMET03076 | |
| 0.197 | 0.003 | 0.197 | ATPase (Vacuolar H+) inhibitor | 0.161 0.005 DBMET00799 0.197 0.003 DBMET03074 0.098 0.042 DBMET03075 0.099 0.041 DBMET00552 0.095 0.047 DBMET03076 0.113 0.025 DBMET03077 | ||
| 0.214 | 0.027 | 0.224 | ATPase inhibitor | 0.205 0.033 DBMET03074 0.147 0.107 DBMET03075 0.224 0.022 DBMET00552 0.222 0.023 DBMET03076 0.191 0.046 DBMET03077 | DBMET00552 | |
| 0.212 | 0.028 | 0.212 | Cyclooxygenase 2 inhibitor | 0.136 0.065 DBMET00799 | ||
| 0.187 | 0.005 | 0.211 | Ca2+-transporting ATPase inhibitor | 0.145 0.057 DBMET00799 0.183 0.006 DBMET03074 0.17 0.013 DBMET03075 0.211 0.003 DBMET00552 0.169 0.014 DBMET03076 0.179 0.008 DBMET03077 | DBMET00552 | |
| 0.283 | 0.102 | 0.373 | Vasodilator, coronary | 0.285 0.1 DBMET03074 0.373 0.045 DBMET03075 0.354 0.053 DBMET00552 0.345 0.058 DBMET03076 0.369 0.047 DBMET03077 | DBMET03075 | |
| 0.203 | 0.025 | 0.209 | Alkylator | 0.199 0.027 DBMET00799 0.205 0.025 DBMET03074 0.209 0.024 DBMET03075 0.179 0.033 DBMET00552 0.186 0.031 DBMET03076 0.148 0.048 DBMET03077 | DBMET03075 | |
| 0.189 | 0.016 | 0.317 | Mucolytic | 0.119 0.055 DBMET00799 0.181 0.019 DBMET03074 0.317 0.004 DBMET03075 0.241 0.007 DBMET00552 0.202 0.013 DBMET03076 0.227 0.009 DBMET03077 | DBMET03075 | |
| 0.203 | 0.03 | 0.249 | Arachidonic acid antagonist | 0.148 0.091 DBMET00799 0.205 0.028 DBMET03074 0.224 0.015 DBMET03075 0.249 0.006 DBMET00552 0.217 0.019 DBMET03076 0.226 0.014 DBMET03077 | DBMET00552 | |
| 0.185 | 0.017 | 0.394 | Adenylate kinase inhibitor | 0.123 0.041 DBMET00799 0.19 0.016 DBMET03074 0.372 0.004 DBMET03075 0.393 0.003 DBMET00552 0.394 0.003 DBMET03076 0.335 0.005 DBMET03077 | DBMET03076 | |
| 0.175 | 0.008 | 0.912 | Alcohol oxidase inhibitor | 0.162 0.009 DBMET03074 0.768 0.003 DBMET03075 0.884 0.002 DBMET00552 0.912 0.002 DBMET03076 0.785 0.003 DBMET03077 | DBMET03076 | |
| 0.197 | 0.031 | 0.364 | Cell wall synthesis inhibitor | 0.364 0.007 DBMET00799 0.192 0.033 DBMET03074 0.199 0.03 DBMET03075 0.26 0.014 DBMET00552 0.176 0.043 DBMET03076 0.19 0.034 DBMET03077 | DBMET00799 | |
| 0.181 | 0.016 | 0.266 | HIV-1 integrase (Overall Integration) inhibitor | 0.122 0.038 DBMET00799 0.163 0.021 DBMET03074 0.175 0.018 DBMET03075 0.266 0.004 DBMET00552 0.097 0.057 DBMET03076 0.135 0.031 DBMET03077 | DBMET00552 | |
| 0.188 | 0.023 | 0.218 | Microtubule formation inhibitor | 0.201 0.019 DBMET03074 0.19 0.022 DBMET03075 0.196 0.021 DBMET00552 0.218 0.016 DBMET03076 0.192 0.022 DBMET03077 | DBMET03076 | |
| 0.175 | 0.013 | 0.434 | NADH dehydrogenase inhibitor | 0.117 0.03 DBMET00799 0.169 0.014 DBMET03074 0.42 0.004 DBMET03075 0.434 0.004 DBMET00552 0.297 0.007 DBMET03076 0.381 0.005 DBMET03077 | DBMET00552 | |
| 0.169 | 0.009 | 0.494 | Carbamoyl phosphate synthetase inhibitor | 0.109 0.018 DBMET00799 0.163 0.01 DBMET03074 0.494 0.002 DBMET03075 0.448 0.003 DBMET00552 0.322 0.004 DBMET03076 0.41 0.003 DBMET03077 | DBMET03075 | |
| 0.183 | 0.023 | 0.239 | Adenylate cyclase stimulant | 0.184 0.023 DBMET00799 0.18 0.026 DBMET03074 0.197 0.015 DBMET03075 0.239 0.005 DBMET00552 0.189 0.02 DBMET03076 0.21 0.01 DBMET03077 | DBMET00552 | |
| 0.275 | 0.118 | 0.423 | Calcium channel activator | 0.285 0.108 DBMET03074 0.222 0.182 DBMET03075 0.423 0.017 DBMET00552 0.235 0.166 DBMET03076 0.282 0.11 DBMET03077 | DBMET00552 | |
| 0.16 | 0.004 | 0.265 | Alpha-mannosidase inhibitor | 0.265 0.003 DBMET00799 0.142 0.004 DBMET03074 0.173 0.004 DBMET03075 0.143 0.004 DBMET00552 0.253 0.003 DBMET03076 0.155 0.004 DBMET03077 | DBMET00799 | |
| 0.225 | 0.069 | 0.378 | RNA-directed DNA polymerase inhibitor | 0.346 0.024 DBMET00799 0.223 0.071 DBMET03074 0.188 0.119 DBMET03075 0.378 0.02 DBMET00552 0.227 0.067 DBMET03076 0.24 0.056 DBMET03077 | DBMET00552 | |
| 0.176 | 0.026 | 0.334 | Expectorant | 0.092 0.078 DBMET00799 0.161 0.031 DBMET03074 0.334 0.007 DBMET03075 0.24 0.014 DBMET00552 0.196 0.021 DBMET03076 0.227 0.015 DBMET03077 | DBMET03075 | |
| 0.217 | 0.07 | 0.217 | Platelet aggregation inhibitor | 0.185 0.093 DBMET00552 | ||
| 0.145 | 0.005 | 0.145 | Interferon inducer | 0.115 0.008 DBMET00799 0.094 0.015 DBMET03074 0.06 0.053 DBMET03075 0.099 0.013 DBMET00552 0.062 0.05 DBMET03076 0.076 0.027 DBMET03077 | ||
| 0.148 | 0.013 | 0.4 | Glutamate decarboxylase inhibitor | 0.085 0.039 DBMET00799 0.137 0.016 DBMET03074 0.354 0.003 DBMET03075 0.4 0.003 DBMET00552 0.398 0.003 DBMET03076 0.26 0.004 DBMET03077 | DBMET00552 | |
| 0.147 | 0.02 | 0.167 | Anabolic | 0.167 0.01 DBMET00799 0.148 0.019 DBMET03074 0.127 0.033 DBMET03075 0.166 0.011 DBMET00552 0.132 0.03 DBMET03076 0.14 0.024 DBMET03077 | DBMET00799 | |
| 0.128 | 0.003 | 0.378 | Glucose-6-phosphate isomerase inhibitor | 0.089 0.006 DBMET00799 0.124 0.003 DBMET03074 0.378 0.001 DBMET03075 0.194 0.002 DBMET00552 0.319 0.001 DBMET03076 0.325 0.001 DBMET03077 | DBMET03075 | |
| 0.142 | 0.019 | 0.142 | Phosphodiesterase I inhibitor | 0.079 0.078 DBMET00552 | ||
| 0.158 | 0.037 | 0.381 | Cystathionine beta-synthase inhibitor | 0.142 0.044 DBMET03074 0.149 0.041 DBMET03075 0.381 0.005 DBMET00552 0.118 0.06 DBMET03076 0.155 0.038 DBMET03077 | DBMET00552 | |
| 0.148 | 0.027 | 0.468 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.152 0.026 DBMET03074 0.468 0.003 DBMET03075 0.462 0.003 DBMET00552 0.335 0.005 DBMET03076 0.406 0.004 DBMET03077 | DBMET03075 | |
| 0.127 | 0.009 | 0.127 | Alpha 2 adrenoreceptor agonist | |||
| 0.2 | 0.082 | 0.2 | Anticonvulsant | 0.142 0.14 DBMET00552 | ||
| 0.15 | 0.034 | 0.769 | GABA C receptor agonist | 0.143 0.037 DBMET03074 0.307 0.009 DBMET03075 0.769 0.002 DBMET00552 0.22 0.017 DBMET03076 0.287 0.01 DBMET03077 | DBMET00552 | |
| 0.141 | 0.028 | 0.324 | Creatine kinase inhibitor | 0.084 0.081 DBMET00799 0.126 0.036 DBMET03074 0.158 0.021 DBMET03075 0.324 0.004 DBMET00552 0.154 0.022 DBMET03076 0.19 0.012 DBMET03077 | DBMET00552 | |
| 0.119 | 0.013 | 0.119 | Cathepsin D inhibitor | 0.051 0.041 DBMET00799 0.05 0.042 DBMET03076 0.057 0.036 DBMET03077 | ||
| 0.126 | 0.02 | 0.126 | Alpha adrenoreceptor agonist | |||
| 0.141 | 0.037 | 0.239 | Photosensitizer | 0.143 0.035 DBMET03074 0.13 0.046 DBMET03075 0.239 0.007 DBMET00552 0.13 0.046 DBMET03076 0.136 0.041 DBMET03077 | DBMET00552 | |
| 0.226 | 0.123 | 0.238 | Hypoxia-inducible factor 1 alpha inhibitor | 0.208 0.143 DBMET03074 0.238 0.112 DBMET00552 0.192 0.162 DBMET03076 | DBMET00552 | |
| 0.151 | 0.049 | 0.158 | Interleukin 4 antagonist | 0.123 0.081 DBMET03074 0.158 0.043 DBMET00552 0.115 0.093 DBMET03076 | DBMET00552 | |
| 0.173 | 0.072 | 0.47 | Dual specificity phosphatase inhibitor | 0.47 0.008 DBMET00799 0.166 0.078 DBMET03074 0.212 0.049 DBMET00552 | DBMET00799 | |
| 0.218 | 0.119 | 0.485 | 5 Hydroxytryptamine uptake stimulant | 0.208 0.136 DBMET03074 0.215 0.124 DBMET03075 0.485 0.005 DBMET00552 0.209 0.134 DBMET03076 0.248 0.083 DBMET03077 | DBMET00552 | |
| 0.115 | 0.019 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.125 0.014 DBMET00799 0.115 0.019 DBMET03074 0.1 0.032 DBMET03075 0.115 0.019 DBMET00552 0.12 0.016 DBMET03076 0.11 0.023 DBMET03077 | DBMET00799 | |
| 0.108 | 0.013 | 0.336 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.101 0.014 DBMET03074 0.31 0.004 DBMET03075 0.24 0.005 DBMET00552 0.336 0.003 DBMET03076 0.269 0.005 DBMET03077 | DBMET03076 | |
| 0.249 | 0.155 | 0.613 | GABA C receptor rho-3 antagonist | 0.248 0.156 DBMET03074 0.271 0.137 DBMET03075 0.613 0.006 DBMET00552 0.296 0.118 DBMET03076 0.372 0.074 DBMET03077 | DBMET00552 | |
| 0.112 | 0.022 | 0.238 | CDC25A inhibitor | 0.238 0.005 DBMET00799 0.124 0.018 DBMET03074 0.137 0.015 DBMET00552 | DBMET00799 | |
| 0.2 | 0.112 | 0.542 | Hypoglycemic | 0.179 0.135 DBMET03074 0.542 0.012 DBMET03075 0.488 0.016 DBMET00552 0.335 0.041 DBMET03076 0.262 0.07 DBMET03077 | DBMET03075 | |
| 0.102 | 0.016 | 0.242 | Neuraminidase (influenza) inhibitor | 0.177 0.005 DBMET00799 0.091 0.019 DBMET03074 0.203 0.005 DBMET03075 0.074 0.031 DBMET00552 0.238 0.004 DBMET03076 0.242 0.004 DBMET03077 | DBMET03077 | |
| 0.132 | 0.046 | 0.563 | Ferrochelatase inhibitor | 0.156 0.035 DBMET03074 0.212 0.02 DBMET03075 0.563 0.002 DBMET00552 0.152 0.037 DBMET03076 0.209 0.02 DBMET03077 | DBMET00552 | |
| 0.104 | 0.019 | 0.214 | Glycine receptor agonist | 0.084 0.034 DBMET03074 0.096 0.023 DBMET03075 0.214 0.004 DBMET00552 0.09 0.028 DBMET03076 0.104 0.019 DBMET03077 | DBMET00552 | |
| 0.14 | 0.055 | 0.231 | DNA polymerase I inhibitor | 0.127 0.063 DBMET03074 0.159 0.044 DBMET03075 0.231 0.02 DBMET00552 0.131 0.061 DBMET03076 0.179 0.036 DBMET03077 | DBMET00552 | |
| 0.096 | 0.014 | 0.102 | Protein 50S ribosomal subunit inhibitor | 0.057 0.033 DBMET00799 0.1 0.013 DBMET03074 0.102 0.013 DBMET03076 | DBMET03076 | |
| 0.113 | 0.032 | 0.34 | Carbonic anhydrase XIII inhibitor | 0.34 0.005 DBMET00799 0.091 0.042 DBMET03074 0.066 0.062 DBMET03075 0.156 0.02 DBMET00552 0.138 0.024 DBMET03076 0.096 0.04 DBMET03077 | DBMET00799 | |
| 0.11 | 0.031 | 0.118 | Interleukin 5 antagonist | 0.118 0.025 DBMET03074 0.104 0.038 DBMET03076 | DBMET03074 | |
| 0.122 | 0.043 | 0.222 | Carbonic anhydrase III inhibitor | 0.121 0.043 DBMET00799 0.101 0.061 DBMET03074 0.086 0.08 DBMET03075 0.222 0.013 DBMET00552 0.106 0.056 DBMET03077 | DBMET00552 | |
| 0.162 | 0.086 | 0.233 | Nitric oxide antagonist | 0.15 0.094 DBMET03074 0.148 0.096 DBMET03075 0.18 0.076 DBMET00552 0.233 0.057 DBMET03076 0.149 0.096 DBMET03077 | DBMET03076 | |
| 0.104 | 0.029 | 0.451 | Glutamate dehydrogenase inhibitor | 0.1 0.031 DBMET03074 0.37 0.004 DBMET03075 0.451 0.004 DBMET00552 0.23 0.008 DBMET03076 0.261 0.007 DBMET03077 | DBMET00552 | |
| 0.092 | 0.018 | 0.246 | Acyl-CoA dehydrogenase inhibitor | 0.088 0.019 DBMET03074 0.205 0.005 DBMET03075 0.246 0.003 DBMET00552 0.188 0.006 DBMET03076 0.217 0.004 DBMET03077 | DBMET00552 | |
| 0.137 | 0.066 | 0.137 | MAO inhibitor | |||
| 0.072 | 0.003 | 0.072 | Alpha 2b adrenoreceptor agonist | 0.027 0.005 DBMET03074 | ||
| 0.086 | 0.021 | 0.234 | Neuraminidase inhibitor | 0.121 0.01 DBMET00799 0.08 0.026 DBMET03074 0.173 0.005 DBMET03075 0.07 0.033 DBMET00552 0.221 0.004 DBMET03076 0.234 0.004 DBMET03077 | DBMET03077 | |
| 0.104 | 0.04 | 0.153 | Ornithine decarboxylase inhibitor | 0.1 0.044 DBMET03074 0.11 0.034 DBMET03075 0.153 0.01 DBMET00552 0.132 0.018 DBMET03076 0.114 0.03 DBMET03077 | DBMET00552 | |
| 0.114 | 0.052 | 0.253 | DOPA decarboxylase inhibitor | 0.106 0.064 DBMET03074 0.148 0.022 DBMET03075 0.253 0.004 DBMET00552 0.145 0.024 DBMET03076 0.152 0.02 DBMET03077 | DBMET00552 | |
| 0.094 | 0.033 | 0.137 | Estrogen-related receptor beta agonist | 0.082 0.061 DBMET03074 0.094 0.033 DBMET03075 0.137 0.005 DBMET00552 0.095 0.032 DBMET03076 0.106 0.018 DBMET03077 | DBMET00552 | |
| 0.143 | 0.081 | 0.143 | Acetylcholine M1 receptor antagonist | 0.125 0.102 DBMET03074 0.136 0.089 DBMET00552 | ||
| 0.094 | 0.034 | 0.23 | Keratolytic | 0.087 0.04 DBMET03074 0.206 0.008 DBMET03075 0.228 0.006 DBMET00552 0.173 0.011 DBMET03076 0.23 0.006 DBMET03077 | DBMET03077 | |
| 0.113 | 0.053 | 0.181 | Carbonic anhydrase XV inhibitor | 0.089 0.085 DBMET00799 0.103 0.063 DBMET03074 0.181 0.022 DBMET00552 0.089 0.084 DBMET03076 0.113 0.052 DBMET03077 | DBMET00552 | |
| 0.083 | 0.023 | 0.166 | Purinergic P2X1 antagonist | 0.067 0.034 DBMET03074 0.066 0.036 DBMET03075 0.166 0.005 DBMET00552 0.083 0.024 DBMET03076 0.085 0.022 DBMET03077 | DBMET00552 | |
| 0.112 | 0.054 | 0.114 | Beta glucuronidase inhibitor | 0.1 0.07 DBMET03074 0.114 0.051 DBMET00552 0.091 0.087 DBMET03076 | DBMET00552 | |
| 0.11 | 0.055 | 0.11 | MAO B inhibitor | |||
| 0.124 | 0.074 | 0.223 | Toll-Like receptor 2 antagonist | 0.113 0.086 DBMET03074 0.171 0.039 DBMET03075 0.223 0.015 DBMET00552 0.178 0.035 DBMET03076 0.183 0.032 DBMET03077 | DBMET00552 | |
| 0.152 | 0.102 | 0.357 | Phospholipase C inhibitor | 0.191 0.05 DBMET00799 0.143 0.121 DBMET03074 0.212 0.037 DBMET03075 0.357 0.014 DBMET00552 0.213 0.037 DBMET03076 0.234 0.029 DBMET03077 | DBMET00552 | |
| 0.148 | 0.098 | 0.462 | Dual specificity phosphatase 3 inhibitor | 0.462 0.009 DBMET00799 0.125 0.123 DBMET03074 0.225 0.049 DBMET00552 | DBMET00799 | |
| 0.108 | 0.06 | 0.264 | Aminopeptidase B inhibitor | 0.158 0.034 DBMET00799 0.098 0.066 DBMET03074 0.219 0.017 DBMET03075 0.264 0.011 DBMET00552 0.243 0.014 DBMET03076 0.216 0.018 DBMET03077 | DBMET00552 | |
| 0.076 | 0.028 | 0.363 | Biliverdin reductase inhibitor | 0.076 0.028 DBMET03074 0.237 0.004 DBMET03075 0.363 0.002 DBMET00552 0.146 0.01 DBMET03076 0.188 0.006 DBMET03077 | DBMET00552 | |
| 0.077 | 0.03 | 0.117 | Exportin-1 inhibitor | 0.083 0.021 DBMET03074 0.079 0.027 DBMET03075 0.117 0.005 DBMET00552 0.096 0.011 DBMET03076 0.094 0.012 DBMET03077 | DBMET00552 | |
| 0.21 | 0.165 | 0.503 | Vasodilator, peripheral | 0.21 0.165 DBMET03074 0.442 0.043 DBMET03075 0.469 0.035 DBMET00552 0.433 0.046 DBMET03076 0.503 0.027 DBMET03077 | DBMET03077 | |
| 0.073 | 0.033 | 0.214 | Glutamate (mGluR6) antagonist | 0.078 0.026 DBMET03074 0.093 0.014 DBMET03075 0.214 0.003 DBMET00552 0.079 0.025 DBMET03076 0.091 0.015 DBMET03077 | DBMET00552 | |
| 0.09 | 0.051 | 0.161 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.071 DBMET03074 0.085 0.062 DBMET03075 0.161 0.004 DBMET00552 0.096 0.041 DBMET03076 0.098 0.037 DBMET03077 | DBMET00552 | |
| 0.06 | 0.02 | 0.108 | Toll-Like receptor 2 agonist | 0.05 0.024 DBMET03074 0.077 0.017 DBMET03075 0.108 0.014 DBMET00552 0.055 0.021 DBMET03076 0.08 0.016 DBMET03077 | DBMET00552 | |
| 0.067 | 0.027 | 0.256 | Ornithine carbamoyltransferase inhibitor | 0.067 0.027 DBMET03074 0.147 0.01 DBMET03075 0.256 0.005 DBMET00552 0.214 0.006 DBMET03076 0.139 0.01 DBMET03077 | DBMET00552 | |
| 0.063 | 0.024 | 0.063 | Epithelial sodium channel blocker | 0.052 0.043 DBMET03075 0.063 0.025 DBMET00552 0.051 0.048 DBMET03076 0.061 0.027 DBMET03077 | ||
| 0.047 | 0.009 | 0.048 | Tubulin agonist | 0.032 0.029 DBMET00799 0.048 0.009 DBMET03074 | DBMET03074 | |
| 0.079 | 0.043 | 0.226 | Aminopeptidase I inhibitor | 0.078 0.044 DBMET03074 0.2 0.007 DBMET03075 0.226 0.005 DBMET00552 0.168 0.01 DBMET03076 0.196 0.007 DBMET03077 | DBMET00552 | |
| 0.121 | 0.085 | 0.173 | Vanilloid 1 agonist | 0.112 0.11 DBMET03074 0.139 0.052 DBMET03075 0.173 0.022 DBMET00552 0.135 0.058 DBMET03076 0.148 0.04 DBMET03077 | DBMET00552 | |
| 0.049 | 0.014 | 0.049 | Antibiotic Aminoglycoside-like | 0.035 0.027 DBMET00799 0.048 0.014 DBMET03074 0.036 0.025 DBMET03076 0.04 0.021 DBMET03077 | ||
| 0.067 | 0.032 | 0.314 | Argininosuccinate synthase inhibitor | 0.083 0.024 DBMET03074 0.146 0.012 DBMET03075 0.314 0.004 DBMET00552 0.224 0.006 DBMET03076 0.139 0.013 DBMET03077 | DBMET00552 | |
| 0.07 | 0.037 | 0.1 | CDC25B inhibitor | 0.079 0.029 DBMET03074 0.1 0.016 DBMET00552 | DBMET00552 | |
| 0.039 | 0.009 | 0.039 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.013 DBMET03074 0.028 0.015 DBMET00552 0.029 0.015 DBMET03076 0.033 0.011 DBMET03077 | ||
| 0.035 | 0.005 | 0.035 | Corticosteroid-like | 0.023 0.013 DBMET00799 0.03 0.007 DBMET03074 | ||
| 0.176 | 0.147 | 0.581 | Superoxide dismutase inhibitor | 0.263 0.067 DBMET00799 0.171 0.154 DBMET03074 0.341 0.038 DBMET03075 0.581 0.008 DBMET00552 0.566 0.008 DBMET03076 0.399 0.027 DBMET03077 | DBMET00552 | |
| 0.057 | 0.029 | 0.398 | Aconitate hydratase inhibitor | 0.064 0.023 DBMET03074 0.313 0.002 DBMET03075 0.398 0.002 DBMET00552 0.172 0.004 DBMET03076 0.222 0.003 DBMET03077 | DBMET00552 | |
| 0.051 | 0.023 | 0.098 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 DBMET03074 0.088 0.004 DBMET03075 0.056 0.016 DBMET00552 0.079 0.005 DBMET03076 0.098 0.004 DBMET03077 | DBMET03077 | |
| 0.074 | 0.047 | 0.413 | Histidine decarboxylase inhibitor | 0.066 0.055 DBMET03074 0.245 0.009 DBMET03075 0.413 0.004 DBMET00552 0.221 0.011 DBMET03076 0.248 0.009 DBMET03077 | DBMET00552 | |
| 0.059 | 0.033 | 0.089 | Pregnane X receptor antagonist | 0.059 0.034 DBMET03074 0.089 0.004 DBMET00552 0.058 0.035 DBMET03076 0.059 0.033 DBMET03077 | DBMET00552 | |
| 0.109 | 0.083 | 0.677 | Aldehyde dehydrogenase inhibitor | 0.109 0.084 DBMET03074 0.28 0.014 DBMET03075 0.308 0.011 DBMET00552 0.677 0.003 DBMET03076 0.331 0.009 DBMET03077 | DBMET03076 | |
| 0.084 | 0.059 | 0.104 | mTOR complex 2 inhibitor | 0.084 0.059 DBMET03074 0.104 0.028 DBMET00552 0.089 0.049 DBMET03077 | DBMET00552 | |
| 0.092 | 0.069 | 0.129 | Bile acid receptor antagonist | 0.103 0.043 DBMET00799 0.129 0.014 DBMET00552 0.086 0.084 DBMET03077 | DBMET00552 | |
| 0.039 | 0.016 | 0.061 | HMG CoA reductase inhibitor | 0.039 0.016 DBMET03074 0.042 0.012 DBMET03075 0.061 0.005 DBMET00552 0.036 0.021 DBMET03076 0.042 0.013 DBMET03077 | DBMET00552 | |
| 0.1 | 0.077 | 0.365 | GABA C receptor antagonist | 0.096 0.085 DBMET03074 0.143 0.034 DBMET03075 0.365 0.004 DBMET00552 0.14 0.036 DBMET03076 0.176 0.019 DBMET03077 | DBMET00552 | |
| 0.127 | 0.105 | 0.694 | Protein-tyrosine phosphatase inhibitor | 0.36 0.011 DBMET00799 0.694 0.004 DBMET00552 | DBMET00552 | |
| 0.027 | 0.004 | 0.027 | Antibiotic Anthracycline-like | 0.025 0.005 DBMET03074 0.019 0.012 DBMET03075 0.026 0.005 DBMET00552 0.021 0.009 DBMET03076 0.025 0.005 DBMET03077 | ||
| 0.04 | 0.018 | 0.387 | Fumarate hydratase inhibitor | 0.04 0.019 DBMET03074 0.263 0.003 DBMET03075 0.387 0.002 DBMET00552 0.1 0.005 DBMET03076 0.143 0.004 DBMET03077 | DBMET00552 | |
| 0.075 | 0.053 | 0.175 | GABA B receptor agonist | 0.11 0.011 DBMET03075 0.175 0.004 DBMET00552 0.101 0.016 DBMET03076 0.114 0.009 DBMET03077 | DBMET00552 | |
| 0.031 | 0.01 | 0.055 | Lysophosphatidic acid receptor 1 agonist | 0.034 0.008 DBMET03074 0.041 0.005 DBMET03075 0.055 0.004 DBMET00552 0.037 0.007 DBMET03076 0.045 0.004 DBMET03077 | DBMET00552 | |
| 0.145 | 0.126 | 0.478 | Angiogenesis stimulant | 0.478 0.013 DBMET00799 0.141 0.128 DBMET03075 0.367 0.028 DBMET00552 | DBMET00799 | |
| 0.03 | 0.011 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET03074 0.026 0.017 DBMET00552 0.026 0.018 DBMET03076 0.029 0.013 DBMET03077 | ||
| 0.09 | 0.071 | 0.151 | Lanosterol 14 alpha demethylase inhibitor | 0.084 0.083 DBMET03074 0.151 0.011 DBMET00552 0.102 0.052 DBMET03076 0.119 0.031 DBMET03077 | DBMET00552 | |
| 0.125 | 0.106 | 0.554 | Anticoagulant | 0.554 0.007 DBMET00799 0.219 0.047 DBMET00552 | DBMET00799 | |
| 0.028 | 0.01 | 0.063 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET03074 0.051 0.004 DBMET03075 0.057 0.004 DBMET00552 0.042 0.005 DBMET03076 0.063 0.003 DBMET03077 | DBMET03077 | |
| 0.035 | 0.017 | 0.035 | Cyclophilin A inhibitor | 0.033 0.018 DBMET03074 | ||
| 0.055 | 0.038 | 0.085 | Glucosylceramidase inhibitor | 0.063 0.027 DBMET00552 0.085 0.013 DBMET03076 0.069 0.023 DBMET03077 | DBMET03076 | |
| 0.029 | 0.014 | 0.046 | Toll-Like receptor 4 agonist | 0.046 0.004 DBMET00799 0.029 0.014 DBMET03074 | DBMET00799 | |
| 0.047 | 0.033 | 0.051 | Microtubule stabilization | 0.051 0.026 DBMET03074 0.041 0.04 DBMET03076 | DBMET03074 | |
| 0.03 | 0.016 | 0.046 | 1,3-Beta-glucan synthase inhibitor | 0.046 0.003 DBMET00799 0.027 0.023 DBMET03074 | DBMET00799 | |
| 0.048 | 0.035 | 0.056 | Cytokine production stimulant | 0.05 0.03 DBMET03074 0.056 0.018 DBMET00552 0.045 0.044 DBMET03076 0.05 0.029 DBMET03077 | DBMET00552 | |
| 0.03 | 0.018 | 0.045 | Purinergic P2Y15 antagonist | 0.028 0.021 DBMET03074 0.045 0.005 DBMET00552 0.03 0.016 DBMET03077 | DBMET00552 | |
| 0.041 | 0.03 | 0.093 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.093 0.003 DBMET00552 0.042 0.028 DBMET03076 0.049 0.016 DBMET03077 | DBMET00552 | |
| 0.126 | 0.114 | 0.296 | GABA C receptor rho-2 antagonist | 0.13 0.105 DBMET03074 0.296 0.005 DBMET00552 0.127 0.111 DBMET03076 0.154 0.068 DBMET03077 | DBMET00552 | |
| 0.069 | 0.057 | 0.674 | Porphobilinogen synthase inhibitor | 0.192 0.013 DBMET03075 0.674 0.002 DBMET00552 0.174 0.016 DBMET03076 0.187 0.014 DBMET03077 | DBMET00552 | |
| 0.074 | 0.065 | 0.102 | MAP kinase kinase 7 inhibitor | 0.102 0.012 DBMET00552 0.077 0.054 DBMET03076 0.087 0.029 DBMET03077 | DBMET00552 | |
| 0.116 | 0.107 | 0.321 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.112 DBMET03074 0.248 0.012 DBMET03075 0.268 0.009 DBMET00552 0.321 0.005 DBMET03076 0.249 0.012 DBMET03077 | DBMET03076 | |
| 0.131 | 0.122 | 0.284 | Interleukin 6 antagonist | 0.284 0.017 DBMET03075 0.17 0.064 DBMET00552 0.197 0.042 DBMET03076 0.176 0.058 DBMET03077 | DBMET03075 | |
| 0.059 | 0.05 | 0.317 | Selectin antagonist | 0.278 0.007 DBMET00799 0.292 0.006 DBMET03075 0.136 0.02 DBMET00552 0.106 0.026 DBMET03076 0.317 0.005 DBMET03077 | DBMET03077 | |
| 0.022 | 0.013 | 0.032 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET03074 0.023 0.01 DBMET03075 0.032 0.004 DBMET00552 0.026 0.007 DBMET03076 0.031 0.004 DBMET03077 | DBMET00552 | |
| 0.018 | 0.01 | 0.032 | Telomerase stimulant | 0.017 0.012 DBMET03074 0.016 0.014 DBMET03075 0.032 0.003 DBMET00552 0.016 0.013 DBMET03076 0.019 0.009 DBMET03077 | DBMET00552 | |
| 0.05 | 0.042 | 0.107 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.031 DBMET03075 0.085 0.014 DBMET00552 0.093 0.012 DBMET03076 0.107 0.009 DBMET03077 | DBMET03077 | |
| 0.013 | 0.006 | 0.015 | Calcineurin inhibitor | 0.015 0.005 DBMET03074 | DBMET03074 | |
| 0.015 | 0.008 | 0.036 | Lysophosphatidic acid receptor 3 agonist | 0.017 0.007 DBMET03074 0.026 0.004 DBMET03075 0.036 0.003 DBMET00552 0.026 0.004 DBMET03076 0.035 0.003 DBMET03077 | DBMET00552 | |
| 0.026 | 0.021 | 0.07 | Uridine phosphorylase inhibitor | 0.024 0.023 DBMET03074 0.051 0.008 DBMET03075 0.066 0.005 DBMET00552 0.057 0.006 DBMET03076 0.07 0.004 DBMET03077 | DBMET03077 | |
| 0.072 | 0.068 | 0.177 | Carbonic anhydrase VI inhibitor | 0.072 0.069 DBMET00799 0.177 0.016 DBMET00552 0.081 0.056 DBMET03077 | DBMET00552 | |
| 0.032 | 0.028 | 0.095 | Phosphoglycerate kinase inhibitor | 0.04 0.02 DBMET00799 0.066 0.01 DBMET03075 0.07 0.009 DBMET00552 0.081 0.008 DBMET03076 0.095 0.007 DBMET03077 | DBMET03077 | |
| 0.063 | 0.06 | 0.469 | HIV-1 integrase inhibitor | 0.122 0.014 DBMET00799 0.321 0.004 DBMET03075 0.469 0.003 DBMET00552 0.106 0.021 DBMET03077 | DBMET00552 | |
| 0.017 | 0.016 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET03075 0.029 0.003 DBMET00552 0.027 0.003 DBMET03076 0.023 0.005 DBMET03077 | DBMET00552 | |
| 0.029 | 0.027 | 0.071 | ATP citrate lysase inhibitor | 0.036 0.016 DBMET03075 0.071 0.004 DBMET00552 0.036 0.017 DBMET03077 | DBMET00552 | |
| 0.008 | 0.006 | 0.906 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET03074 0.597 0 DBMET03075 0.012 0.004 DBMET00552 0.077 0.001 DBMET03076 0.906 0 DBMET03077 | DBMET03077 | |
| 0.054 | 0.053 | 0.069 | Lipocortins synthesis agonist | 0.058 0.04 DBMET03074 0.056 0.044 DBMET03075 0.069 0.023 DBMET00552 0.055 0.049 DBMET03076 0.058 0.039 DBMET03077 | DBMET00552 | |
| 0.058 | 0.058 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.028 DBMET00552 0.061 0.045 DBMET03077 | DBMET00552 | |
| 0.012 | 0.012 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET03074 | DBMET03074 | |
| 0.01 | 0.011 | 0.011 | Immunosuppressant Cyclosporine-like | 0.011 0.009 DBMET03074 | DBMET03074 | |
| 0.026 | 0.028 | 0.081 | Prostaglandin D2 agonist | 0.027 0.026 DBMET03074 0.041 0.012 DBMET03075 0.081 0.004 DBMET00552 0.029 0.024 DBMET03076 0.035 0.017 DBMET03077 | DBMET00552 | |
| 0.048 | 0.05 | 0.07 | Leukotriene B4 antagonist | 0.056 0.034 DBMET00799 0.052 0.04 DBMET03075 0.07 0.02 DBMET00552 0.052 0.04 DBMET03077 | DBMET00552 | |
| 0.018 | 0.02 | 0.051 | Prostaglandin EP2 agonist | 0.021 0.017 DBMET03074 0.05 0.005 DBMET03075 0.051 0.005 DBMET00552 0.027 0.014 DBMET03076 0.038 0.009 DBMET03077 | DBMET00552 | |
| 0.065 | 0.067 | 0.145 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.094 0.041 DBMET03075 0.145 0.02 DBMET00552 0.083 0.048 DBMET03076 0.092 0.042 DBMET03077 | DBMET00552 | |
| 0.182 | 0.185 | 0.833 | Nootropic | 0.833 0.004 DBMET03074 | DBMET03074 | |
| 0.021 | 0.026 | 0.072 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.046 0.01 DBMET03075 0.062 0.007 DBMET00552 0.072 0.005 DBMET03076 0.06 0.007 DBMET03077 | DBMET03076 | |
| 0.014 | 0.019 | 0.024 | Vitamin D receptor agonist | 0.022 0.006 DBMET03075 0.019 0.008 DBMET00552 0.02 0.007 DBMET03076 0.024 0.005 DBMET03077 | DBMET03077 | |
| 0.022 | 0.027 | 0.044 | Vanilloid 2 agonist | 0.044 0.004 DBMET00552 0.024 0.02 DBMET03077 | DBMET00552 | |
| 0.031 | 0.036 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.044 0.011 DBMET00552 0.033 0.03 DBMET03077 | DBMET00552 | |
| 0.033 | 0.039 | 0.131 | Glutamate (mGluR8) agonist | 0.048 0.013 DBMET03075 0.131 0.002 DBMET00552 0.042 0.02 DBMET03076 0.046 0.014 DBMET03077 | DBMET00552 | |
| 0.043 | 0.049 | 0.101 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 DBMET03074 0.07 0.014 DBMET03075 0.101 0.005 DBMET00552 0.062 0.021 DBMET03076 0.073 0.012 DBMET03077 | DBMET00552 | |
| 0.028 | 0.035 | 0.075 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET03075 0.075 0.003 DBMET00552 0.031 0.026 DBMET03076 0.035 0.017 DBMET03077 | DBMET00552 | |
| 0.012 | 0.02 | 0.023 | Purinergic P2Y1 agonist | 0.023 0.005 DBMET00552 0.015 0.013 DBMET03077 | DBMET00552 | |
| 0.084 | 0.093 | 0.125 | Phosphodiesterase 6D inhibitor | 0.092 0.071 DBMET03075 0.106 0.042 DBMET00552 0.11 0.036 DBMET03076 0.125 0.021 DBMET03077 | DBMET03077 | |
| 0.019 | 0.027 | 0.025 | Vitamin D receptor antagonist | 0.023 0.013 DBMET03075 0.021 0.017 DBMET03076 0.025 0.01 DBMET03077 | DBMET03077 | |
| 0.043 | 0.052 | 0.115 | Carbonic anhydrase VB inhibitor | 0.1 0.016 DBMET00799 0.115 0.013 DBMET00552 0.052 0.042 DBMET03077 | DBMET00552 | |
| 0.057 | 0.066 | 0.075 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 DBMET00552 0.062 0.049 DBMET03076 0.075 0.028 DBMET03077 | DBMET03077 | |
| 0.011 | 0.021 | 0.16 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.16 0.003 DBMET03076 | DBMET03076 | |
| 0.044 | 0.055 | 0.049 | Factor III inhibitor | 0.049 0.037 DBMET00552 | DBMET00552 | |
| 0.024 | 0.035 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET00552 0.028 0.022 DBMET03076 0.033 0.012 DBMET03077 | DBMET00552 | |
| 0.023 | 0.035 | 0.077 | Prostaglandin agonist | 0.071 0.007 DBMET03075 0.067 0.008 DBMET00552 0.034 0.018 DBMET03076 0.077 0.007 DBMET03077 | DBMET03077 | |
| 0.032 | 0.044 | 0.098 | Membrane dipeptidase inhibitor | 0.057 0.011 DBMET03075 0.098 0.004 DBMET00552 0.041 0.025 DBMET03076 0.047 0.018 DBMET03077 | DBMET00552 | |
| 0.034 | 0.046 | 0.076 | Guanylate cyclase inhibitor | 0.072 0.004 DBMET03075 0.076 0.004 DBMET00552 0.067 0.006 DBMET03076 0.073 0.004 DBMET03077 | DBMET00552 | |
| 0.018 | 0.031 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.023 0.014 DBMET03075 0.031 0.005 DBMET00552 0.024 0.013 DBMET03076 0.027 0.008 DBMET03077 | DBMET00552 | |
| 0.006 | 0.02 | 0.029 | Thromboxane agonist | 0.016 0.004 DBMET03075 0.029 0.003 DBMET00552 0.013 0.005 DBMET03076 0.016 0.005 DBMET03077 | DBMET00552 | |
| 0.034 | 0.048 | 0.101 | Adenosine deaminase inhibitor | 0.069 0.014 DBMET03075 0.077 0.01 DBMET00552 0.101 0.005 DBMET03076 0.08 0.009 DBMET03077 | DBMET03076 | |
| 0.075 | 0.089 | 0.27 | Alcohol dehydrogenase inhibitor | 0.22 0.01 DBMET03075 0.25 0.008 DBMET00552 0.27 0.006 DBMET03076 0.161 0.018 DBMET03077 | DBMET03076 | |
| 0.035 | 0.05 | 0.128 | Kainate receptor agonist | 0.047 0.017 DBMET03075 0.128 0.002 DBMET00552 0.039 0.034 DBMET03076 0.046 0.02 DBMET03077 | DBMET00552 | |
| 0.077 | 0.092 | 0.176 | Sphingomyelinase inhibitor | 0.089 0.073 DBMET03074 0.139 0.03 DBMET03075 0.137 0.03 DBMET00552 0.141 0.029 DBMET03076 0.176 0.015 DBMET03077 | DBMET03077 | |
| 0.074 | 0.09 | 0.095 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.051 DBMET00552 | DBMET00552 | |
| 0.023 | 0.039 | 0.051 | Calcitonin receptor agonist | 0.037 0.021 DBMET03075 0.051 0.016 DBMET00552 0.037 0.022 DBMET03076 0.039 0.02 DBMET03077 | DBMET00552 | |
| 0.085 | 0.1 | 0.134 | Anesthetic local | 0.12 0.067 DBMET00552 0.134 0.057 DBMET03076 0.12 0.067 DBMET03077 | DBMET03076 | |
| 0.006 | 0.026 | 0.062 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET03075 0.062 0.002 DBMET00552 | DBMET00552 | |
| 0.006 | 0.027 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00552 | DBMET00552 | |
| 0.126 | 0.147 | 0.187 | Heat shock protein 70 antagonist | 0.187 0.009 DBMET00552 0.133 0.107 DBMET03077 | DBMET00552 | |
| 0.079 | 0.102 | 0.296 | GABA C receptor rho-1 antagonist | 0.13 0.032 DBMET03075 0.296 0.004 DBMET00552 0.126 0.035 DBMET03076 0.158 0.018 DBMET03077 | DBMET00552 | |
| 0.013 | 0.037 | 0.041 | Prostaglandin E2 agonist | 0.039 0.007 DBMET03075 0.041 0.007 DBMET00552 0.021 0.019 DBMET03076 0.028 0.012 DBMET03077 | DBMET00552 | |
| 0.05 | 0.075 | 0.076 | Beta adrenoreceptor antagonist | 0.073 0.034 DBMET00552 0.07 0.038 DBMET03076 0.076 0.03 DBMET03077 | DBMET03077 | |
| 0.01 | 0.035 | 0.04 | Thromboxane A2 agonist | 0.022 0.005 DBMET03075 0.04 0.002 DBMET00552 0.02 0.005 DBMET03076 0.022 0.005 DBMET03077 | DBMET00552 | |
| 0.08 | 0.106 | 0.197 | Adenylate cyclase inhibitor | 0.147 0.047 DBMET03075 0.197 0.026 DBMET00552 0.105 0.08 DBMET03076 0.139 0.052 DBMET03077 | DBMET00552 | |
| 0.049 | 0.075 | 0.079 | Leukotriene C antagonist | 0.058 0.033 DBMET03075 0.079 0.008 DBMET00552 0.058 0.033 DBMET03077 | DBMET00552 | |
| 0.009 | 0.036 | 0.061 | Carbonic anhydrase X inhibitor | 0.02 0.008 DBMET03075 0.061 0.002 DBMET00552 0.016 0.013 DBMET03076 0.021 0.008 DBMET03077 | DBMET00552 | |
| 0.009 | 0.036 | 0.061 | Carbonic anhydrase VIII inhibitor | 0.02 0.008 DBMET03075 0.061 0.002 DBMET00552 0.016 0.013 DBMET03076 0.021 0.008 DBMET03077 | DBMET00552 | |
| 0.06 | 0.088 | 0.135 | Macrophage migration inhibitory factor inhibitor | 0.135 0.02 DBMET00552 | DBMET00552 | |
| 0.008 | 0.037 | 0.028 | Ileal bile acid transport inhibitor | 0.019 0.009 DBMET03075 0.028 0.005 DBMET00552 0.015 0.014 DBMET03077 | DBMET00552 | |
| 0.081 | 0.111 | 0.169 | Toll-Like receptor 4 antagonist | 0.117 0.047 DBMET03075 0.169 0.013 DBMET00552 0.098 0.074 DBMET03076 0.117 0.047 DBMET03077 | DBMET00552 | |
| 0.151 | 0.181 | 0.556 | 5 Hydroxytryptamine release stimulant | 0.335 0.06 DBMET03075 0.556 0.019 DBMET00552 0.442 0.038 DBMET03076 0.553 0.02 DBMET03077 | DBMET00552 | |
| 0.045 | 0.075 | 0.242 | HIV-1 integrase (3'-Processing) inhibitor | 0.242 0.007 DBMET00799 0.138 0.015 DBMET03075 0.157 0.013 DBMET00552 0.058 0.049 DBMET03076 | DBMET00799 | |
| 0.077 | 0.108 | 0.114 | Interleukin 12 antagonist | 0.114 0.035 DBMET00552 | DBMET00552 | |
| 0.021 | 0.053 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.022 DBMET03075 0.032 0.009 DBMET00552 0.03 0.012 DBMET03076 0.034 0.007 DBMET03077 | DBMET03077 | |
| 0.046 | 0.078 | 0.097 | Adenine nucleotide translocase inhibitor | 0.09 0.005 DBMET00799 0.097 0.005 DBMET00552 | DBMET00552 | |
| 0.038 | 0.071 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.029 DBMET00552 0.044 0.038 DBMET03077 | DBMET00552 | |
| 0.082 | 0.116 | 0.098 | Acetylcholine muscarinic antagonist | 0.098 0.094 DBMET00552 | DBMET00552 | |
| 0.016 | 0.05 | 0.095 | Arginase inhibitor | 0.04 0.022 DBMET03075 0.095 0.004 DBMET00552 0.039 0.023 DBMET03077 | DBMET00552 | |
| 0.038 | 0.074 | 0.06 | Squalene epoxidase inhibitor | 0.06 0.021 DBMET00552 0.05 0.033 DBMET03077 | DBMET00552 | |
| 0.029 | 0.066 | 0.061 | Thymidine kinase inhibitor | 0.042 0.026 DBMET03075 0.061 0.013 DBMET00552 0.05 0.019 DBMET03076 0.06 0.014 DBMET03077 | DBMET00552 | |
| 0.031 | 0.068 | 0.055 | Leukotriene C4 antagonist | 0.037 0.032 DBMET03075 0.055 0.008 DBMET00552 0.037 0.032 DBMET03077 | DBMET00552 | |
| 0.036 | 0.073 | 0.072 | Beta 1 adrenoreceptor antagonist | 0.066 0.03 DBMET00552 0.071 0.025 DBMET03076 0.072 0.024 DBMET03077 | DBMET03077 | |
| 0.033 | 0.069 | 0.058 | Beta 2 adrenoreceptor antagonist | 0.058 0.026 DBMET00552 0.055 0.03 DBMET03076 0.057 0.027 DBMET03077 | DBMET00552 | |
| 0.015 | 0.053 | 0.085 | Lysine carboxypeptidase inhibitor | 0.034 0.013 DBMET03075 0.085 0.004 DBMET00552 0.025 0.021 DBMET03076 0.032 0.014 DBMET03077 | DBMET00552 | |
| 0.04 | 0.079 | 0.084 | Thromboxane synthase inhibitor | 0.052 0.044 DBMET03074 0.084 0.01 DBMET00552 | DBMET00552 | |
| 0.037 | 0.076 | 0.117 | Elastase inhibitor | 0.117 0.007 DBMET00799 | DBMET00799 | |
| 0.036 | 0.075 | 0.126 | Factor IXa inhibitor | 0.126 0.005 DBMET00799 0.046 0.044 DBMET00552 | DBMET00799 | |
| 0.031 | 0.07 | 0.07 | Carbonic anhydrase XIV inhibitor | 0.07 0.02 DBMET00552 | DBMET00552 | |
| 0.056 | 0.096 | 0.201 | GABA aminotransferase inhibitor | 0.079 0.048 DBMET03075 0.201 0.004 DBMET00552 0.078 0.049 DBMET03076 0.083 0.042 DBMET03077 | DBMET00552 | |
| 0.027 | 0.068 | 0.085 | Thromboxane A2 antagonist | 0.085 0.012 DBMET00552 | DBMET00552 | |
| 0.006 | 0.049 | 0.018 | Retinoic acid receptor gamma antagonist | 0.018 0.004 DBMET00552 | DBMET00552 | |
| 0.074 | 0.116 | 0.184 | Glutamate release inhibitor | 0.134 0.014 DBMET03075 0.184 0.005 DBMET00552 0.112 0.029 DBMET03076 0.129 0.017 DBMET03077 | DBMET00552 | |
| 0.011 | 0.054 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 DBMET00552 | DBMET00552 | |
| 0.026 | 0.069 | 0.05 | HIV-1 protease inhibitor | 0.05 0.021 DBMET03076 0.049 0.022 DBMET03077 | DBMET03076 | |
| 0.104 | 0.147 | 0.166 | Farnesoid X receptor antagonist | 0.166 0.038 DBMET00552 | DBMET00552 | |
| 0.042 | 0.085 | 0.179 | Carbonic anhydrase V inhibitor | 0.179 0.009 DBMET00799 0.131 0.019 DBMET00552 | DBMET00799 | |
| 0.007 | 0.051 | 0.088 | Prostacyclin agonist | 0.018 0.009 DBMET03075 0.088 0.003 DBMET00552 0.045 0.005 DBMET03077 | DBMET00552 | |
| 0.027 | 0.071 | 0.085 | Ribonucleotide reductase inhibitor | 0.075 0.028 DBMET03075 0.085 0.025 DBMET00552 0.074 0.029 DBMET03076 0.063 0.034 DBMET03077 | DBMET00552 | |
| 0.027 | 0.071 | 0.084 | Ribonucleoside-diphosphate reductase inhibitor | 0.073 0.027 DBMET03075 0.084 0.023 DBMET00552 0.072 0.028 DBMET03076 0.061 0.034 DBMET03077 | DBMET00552 | |
| 0.048 | 0.093 | 0.09 | Ryanodine receptor antagonist | 0.09 0.005 DBMET00552 | DBMET00552 | |
| 0.035 | 0.081 | 0.051 | Heme oxygenase inhibitor | 0.051 0.012 DBMET00552 0.043 0.03 DBMET03076 0.048 0.016 DBMET03077 | DBMET00552 | |
| 0.029 | 0.075 | 0.093 | Thromboxane antagonist | 0.093 0.014 DBMET00552 | DBMET00552 | |
| 0.006 | 0.053 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET00552 0.011 0.009 DBMET03076 0.012 0.008 DBMET03077 | DBMET03077 | |
| 0.015 | 0.062 | 0.047 | Nicotinic acid receptor 2 antagonist | 0.047 0.004 DBMET00552 | DBMET00552 | |
| 0.008 | 0.055 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.014 DBMET00552 | DBMET00552 | |
| 0.034 | 0.082 | 0.284 | HIV-1 integrase (Strand Transfer) inhibitor | 0.258 0.006 DBMET00799 0.284 0.005 DBMET03075 0.21 0.009 DBMET00552 0.071 0.035 DBMET03076 | DBMET03075 | |
| 0.044 | 0.094 | 0.121 | Carbonic anhydrase VA inhibitor | 0.121 0.018 DBMET00799 0.12 0.018 DBMET00552 | DBMET00799 | |
| 0.004 | 0.055 | 0.054 | Prostaglandin EP4 agonist | 0.054 0.005 DBMET00552 | DBMET00552 | |
| 0.057 | 0.108 | 0.15 | Glycine receptor antagonist | 0.105 0.028 DBMET00799 0.15 0.007 DBMET00552 | DBMET00552 | |
| 0.023 | 0.076 | 0.087 | Dopamine D5 agonist | 0.087 0.005 DBMET00552 | DBMET00552 | |
| 0.067 | 0.121 | 0.144 | D-Ala-D-Ala ligase inhibitor | 0.144 0.006 DBMET00552 0.084 0.057 DBMET03077 | DBMET00552 | |
| 0.037 | 0.092 | 0.084 | Sphingosine kinase 2 inhibitor | 0.067 0.024 DBMET00552 0.066 0.025 DBMET03076 0.084 0.013 DBMET03077 | DBMET03077 | |
| 0.023 | 0.078 | 0.092 | GABA uptake inhibitor | 0.039 0.027 DBMET03075 0.092 0.004 DBMET00552 0.063 0.009 DBMET03076 0.051 0.015 DBMET03077 | DBMET00552 | |
| 0.034 | 0.089 | 0.084 | Topoisomerase II beta inhibitor | 0.084 0.012 DBMET00552 | DBMET00552 | |
| 0.039 | 0.094 | 0.093 | Dihydroorotate oxidase inhibitor | 0.093 0.006 DBMET00552 0.052 0.046 DBMET03077 | DBMET00552 | |
| 0.015 | 0.071 | 0.048 | Thyroid hormone agonist | 0.048 0.005 DBMET00552 | DBMET00552 | |
| 0.06 | 0.117 | 0.147 | Glutathione S-transferase inhibitor | 0.095 0.042 DBMET03075 0.147 0.013 DBMET00552 0.099 0.038 DBMET03076 0.102 0.035 DBMET03077 | DBMET00552 | |
| 0.003 | 0.062 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 DBMET00552 | DBMET00552 | |
| 0.095 | 0.153 | 0.158 | DNA repair enzyme inhibitor | 0.117 0.079 DBMET03075 0.158 0.025 DBMET00552 0.114 0.085 DBMET03077 | DBMET00552 | |
| 0.008 | 0.067 | 0.043 | Retinoic acid receptor antagonist | 0.043 0.004 DBMET00552 | DBMET00552 | |
| 0.004 | 0.064 | 0.02 | Retinoic acid beta receptor antagonist | 0.02 0.004 DBMET00552 | DBMET00552 | |
| 0.012 | 0.071 | 0.026 | Caspase 8 inhibitor | 0.026 0.006 DBMET00552 0.019 0.014 DBMET03076 | DBMET00552 | |
| 0.01 | 0.071 | 0.072 | Leukotriene B4 receptor 1 antagonist | 0.072 0.004 DBMET00552 | DBMET00552 | |
| 0.016 | 0.078 | 0.07 | Lysophosphatidic acid 2 receptor antagonist | 0.07 0.005 DBMET00552 0.032 0.019 DBMET03077 | DBMET00552 | |
| 0.069 | 0.13 | 0.304 | Chelator | 0.252 0.016 DBMET03075 0.304 0.01 DBMET00552 0.094 0.087 DBMET03077 | DBMET00552 | |
| 0.013 | 0.076 | 0.042 | Retinoic acid gamma receptor agonist | 0.042 0.004 DBMET00552 | DBMET00552 | |
| 0.038 | 0.101 | 0.092 | Leukotriene antagonist | 0.092 0.025 DBMET00552 | DBMET00552 | |
| 0.008 | 0.071 | 0.045 | Estrogen receptor beta agonist | 0.045 0.02 DBMET00799 | DBMET00799 | |
| 0.004 | 0.07 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET00552 | DBMET00552 | |
| 0.043 | 0.111 | 0.137 | Cathepsin G inhibitor | 0.115 0.028 DBMET00799 0.137 0.023 DBMET00552 0.089 0.038 DBMET03076 | DBMET00552 | |
| 0.012 | 0.081 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 DBMET03075 0.027 0.005 DBMET00552 0.023 0.009 DBMET03076 0.028 0.005 DBMET03077 | DBMET03077 | |
| 0.023 | 0.091 | 0.048 | Potassium channel Kv1.3 blocker | 0.048 0.031 DBMET00552 | DBMET00552 | |
| 0.035 | 0.104 | 0.056 | Fatty acid synthase inhibitor | 0.056 0.04 DBMET00552 | DBMET00552 | |
| 0.04 | 0.109 | 0.208 | NMDA receptor agonist | 0.208 0.004 DBMET00552 | DBMET00552 | |
| 0.07 | 0.141 | 0.111 | Protein kinase C gamma inhibitor | 0.111 0.061 DBMET00552 | DBMET00552 | |
| 0.123 | 0.194 | 0.24 | Spasmolytic | 0.24 0.096 DBMET00552 0.196 0.123 DBMET03076 0.211 0.11 DBMET03077 | DBMET00552 | |
| 0.034 | 0.105 | 0.076 | Heparanase inhibitor | 0.063 0.018 DBMET00799 0.056 0.03 DBMET03075 0.076 0.008 DBMET00552 0.053 0.036 DBMET03076 0.051 0.042 DBMET03077 | DBMET00552 | |
| 0.024 | 0.097 | 0.085 | Xanthine dehydrogenase inhibitor | 0.085 0.021 DBMET00552 0.057 0.04 DBMET03076 | DBMET00552 | |
| 0.02 | 0.094 | 0.088 | Erythropoietin receptor agonist | 0.088 0.011 DBMET00552 | DBMET00552 | |
| 0.087 | 0.161 | 0.137 | Antibacterial (Helicobacter pylori) | 0.137 0.059 DBMET00552 | DBMET00552 | |
| 0.005 | 0.08 | 0.029 | Aminopeptidase A inhibitor | 0.029 0.007 DBMET00552 | DBMET00552 | |
| 0.03 | 0.107 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.017 DBMET00552 | DBMET00552 | |
| 0.012 | 0.09 | 0.042 | Retinoid X beta receptor antagonist | 0.042 0.003 DBMET00552 | DBMET00552 | |
| 0.025 | 0.103 | 0.046 | Calcium-independent phospholipase A2 inhibitor | 0.042 0.008 DBMET03075 0.035 0.019 DBMET00552 0.043 0.007 DBMET03076 0.046 0.005 DBMET03077 | DBMET03077 | |
| 0.053 | 0.131 | 0.095 | Antineoplastic alkaloid | 0.095 0.051 DBMET00552 | DBMET00552 | |
| 0.059 | 0.137 | 0.678 | Protein-tyrosine phosphatase 1B inhibitor | 0.19 0.032 DBMET00799 0.678 0.003 DBMET00552 | DBMET00552 | |
| 0.01 | 0.093 | 0.033 | Lysophosphatidic acid 1 receptor antagonist | 0.033 0.005 DBMET00552 | DBMET00552 | |
| 0.011 | 0.094 | 0.05 | Retinoic acid receptor agonist | 0.05 0.005 DBMET00552 | DBMET00552 | |
| 0.017 | 0.102 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.027 DBMET00552 | DBMET00552 | |
| 0.054 | 0.139 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.051 DBMET00552 | DBMET00552 | |
| 0.014 | 0.099 | 0.122 | Estrogen agonist | 0.122 0.014 DBMET00799 | DBMET00799 | |
| 0.03 | 0.115 | 0.052 | Potassium channel (ATP-sensitive) activator | 0.052 0.026 DBMET00552 | DBMET00552 | |
| 0.066 | 0.152 | 0.079 | T cell inhibitor | 0.079 0.069 DBMET03074 | DBMET03074 | |
| 0.009 | 0.096 | 0.042 | Leukotriene B4 receptor 2 antagonist | 0.042 0.005 DBMET00552 | DBMET00552 | |
| 0.031 | 0.118 | 0.055 | Potassium channel (Inward rectifier) activator | 0.055 0.027 DBMET00552 | DBMET00552 | |
| 0.033 | 0.121 | 0.165 | Sphingosine 1-phosphate receptor 4 agonist | 0.096 0.027 DBMET03075 0.165 0.006 DBMET00552 0.09 0.031 DBMET03076 0.106 0.022 DBMET03077 | DBMET00552 | |
| 0.011 | 0.099 | 0.101 | Retinoid X receptor agonist | 0.101 0.005 DBMET00552 | DBMET00552 | |
| 0.013 | 0.102 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.031 0.024 DBMET00552 | DBMET00552 | |
| 0.04 | 0.13 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.088 0.022 DBMET00552 0.09 0.02 DBMET03076 0.065 0.044 DBMET03077 | DBMET03076 | |
| 0.02 | 0.111 | 0.09 | Retinoic acid alpha receptor agonist | 0.09 0.004 DBMET00552 | DBMET00552 | |
| 0.064 | 0.155 | 0.151 | MAP kinase kinase 1 inhibitor | 0.112 0.043 DBMET00552 0.133 0.025 DBMET03076 0.151 0.016 DBMET03077 | DBMET03077 | |
| 0.089 | 0.181 | 0.272 | Psychostimulant | 0.134 0.132 DBMET03075 0.272 0.051 DBMET00552 | DBMET00552 | |
| 0.018 | 0.11 | 0.036 | Hedgehog signaling activator | 0.036 0.006 DBMET00552 0.026 0.024 DBMET03076 0.03 0.013 DBMET03077 | DBMET00552 | |
| 0.016 | 0.108 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DBMET00552 0.025 0.021 DBMET03077 | DBMET00552 | |
| 0.064 | 0.157 | 0.17 | Proteasome inhibitor | 0.118 0.067 DBMET00552 0.17 0.036 DBMET03076 | DBMET03076 | |
| 0.004 | 0.098 | 0.033 | G-protein-coupled receptor 120 agonist | 0.033 0.005 DBMET00552 | DBMET00552 | |
| 0.068 | 0.162 | 0.167 | Caspase 3 inhibitor | 0.099 0.094 DBMET03075 0.167 0.018 DBMET00552 0.151 0.027 DBMET03076 0.106 0.082 DBMET03077 | DBMET00552 | |
| 0.013 | 0.108 | 0.032 | ICAM 1 antagonist | 0.032 0.005 DBMET00552 | DBMET00552 | |
| 0.013 | 0.111 | 0.117 | Retinoid X alpha receptor agonist | 0.117 0.004 DBMET00552 | DBMET00552 | |
| 0.017 | 0.116 | 0.085 | Antimetabolite | 0.045 0.035 DBMET03075 0.085 0.019 DBMET00552 0.048 0.033 DBMET03076 | DBMET00552 | |
| 0.005 | 0.105 | 0.018 | Integrin alphaVbeta6 antagonist | 0.018 0.007 DBMET00552 | DBMET00552 | |
| 0.037 | 0.137 | 0.054 | Cathepsin E inhibitor | 0.054 0.05 DBMET03077 | DBMET03077 | |
| 0.016 | 0.117 | 0.057 | Oxytocin agonist | 0.057 0.019 DBMET00552 | DBMET00552 | |
| 0.034 | 0.137 | 0.104 | Sphingosine kinase inhibitor | 0.058 0.042 DBMET03075 0.067 0.028 DBMET00552 0.104 0.007 DBMET03076 0.096 0.009 DBMET03077 | DBMET03076 | |
| 0.006 | 0.11 | 0.03 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 DBMET00552 | DBMET00552 | |
| 0.011 | 0.115 | 0.067 | Caspase 2 inhibitor | 0.067 0.008 DBMET00552 0.034 0.02 DBMET03076 | DBMET00552 | |
| 0.006 | 0.11 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.015 DBMET00552 | DBMET00552 | |
| 0.024 | 0.131 | 0.153 | NMDA receptor glycine site agonist | 0.153 0.004 DBMET00552 | DBMET00552 | |
| 0.008 | 0.116 | 0.143 | Glutamate (mGluR1a) agonist | 0.143 0.003 DBMET00552 | DBMET00552 | |
| 0.051 | 0.159 | 0.211 | Prolactin inhibitor | 0.211 0.007 DBMET00552 0.109 0.047 DBMET03076 0.099 0.057 DBMET03077 | DBMET00552 | |
| 0.021 | 0.13 | 0.066 | Sphingosine kinase 1 inhibitor | 0.043 0.026 DBMET00552 0.052 0.014 DBMET03076 0.066 0.007 DBMET03077 | DBMET03077 | |
| 0.02 | 0.129 | 0.069 | Retinoid X receptor antagonist | 0.069 0.004 DBMET00552 | DBMET00552 | |
| 0.045 | 0.154 | 0.068 | Transcription factor RelA inhibitor | 0.068 0.034 DBMET00552 | DBMET00552 | |
| 0.025 | 0.135 | 0.049 | Cholesterol esterase inhibitor | 0.049 0.031 DBMET00552 | DBMET00552 | |
| 0.023 | 0.135 | 0.09 | Adenylate cyclase 1 inhibitor | 0.09 0.005 DBMET00552 0.053 0.024 DBMET03077 | DBMET00552 | |
| 0.059 | 0.172 | 0.285 | Electrolyte absorption antagonist | 0.121 0.035 DBMET03075 0.285 0.004 DBMET00552 0.122 0.034 DBMET03076 0.135 0.026 DBMET03077 | DBMET00552 | |
| 0.05 | 0.164 | 0.115 | Vanilloid 4 agonist | 0.07 0.065 DBMET03075 0.115 0.009 DBMET00552 0.074 0.055 DBMET03076 0.086 0.031 DBMET03077 | DBMET00552 | |
| 0.028 | 0.143 | 0.102 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.102 0.016 DBMET00552 | DBMET00552 | |
| 0.032 | 0.148 | 0.076 | Protein kinase C beta inhibitor | 0.076 0.037 DBMET00552 | DBMET00552 | |
| 0.018 | 0.134 | 0.06 | Retinoid X alpha receptor antagonist | 0.06 0.004 DBMET00552 | DBMET00552 | |
| 0.045 | 0.162 | 0.12 | Urease inhibitor | 0.12 0.045 DBMET00552 | DBMET00552 | |
| 0.009 | 0.126 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 DBMET00552 | DBMET00552 | |
| 0.003 | 0.122 | 0.025 | Carbonic anhydrase XI inhibitor | 0.025 0.003 DBMET00552 | DBMET00552 | |
| 0.031 | 0.15 | 0.092 | CD45 antagonist | 0.092 0.01 DBMET00552 | DBMET00552 | |
| 0.009 | 0.129 | 0.043 | Retinoic acid beta receptor agonist | 0.043 0.004 DBMET00552 | DBMET00552 | |
| 0.029 | 0.15 | 0.067 | Bombesin 2 receptor antagonist | 0.067 0.021 DBMET00552 0.046 0.039 DBMET03077 | DBMET00552 | |
| 0.003 | 0.126 | 0.032 | Peroxisome proliferator-activated receptor alpha antagonist | 0.032 0.011 DBMET00552 | DBMET00552 | |
| 0.004 | 0.127 | 0.044 | Prostaglandin H2 antagonist | 0.044 0.005 DBMET00552 | DBMET00552 | |
| 0.078 | 0.202 | 0.132 | Transcription factor STAT6 inhibitor | 0.132 0.041 DBMET00552 | DBMET00552 | |
| 0.013 | 0.137 | 0.07 | Dihydropteroate synthase inhibitor | 0.07 0.008 DBMET00552 | DBMET00552 | |
| 0.06 | 0.186 | 0.139 | Nav1.4 sodium channel blocker | 0.139 0.039 DBMET00799 0.114 0.058 DBMET00552 | DBMET00799 | |
| 0.037 | 0.166 | 0.139 | Glutamate (mGluR7) antagonist | 0.139 0.004 DBMET00552 0.066 0.051 DBMET03077 | DBMET00552 | |
| 0.021 | 0.151 | 0.093 | AICAR transformylase inhibitor | 0.093 0.005 DBMET00552 0.046 0.027 DBMET03076 | DBMET00552 | |
| 0.004 | 0.134 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.021 0.004 DBMET00552 | DBMET00552 | |
| 0.01 | 0.142 | 0.068 | Nicotinic acid receptor agonist | 0.068 0.009 DBMET00552 | DBMET00552 | |
| 0.033 | 0.167 | 0.109 | Topoisomerase II alpha inhibitor | 0.109 0.034 DBMET03076 | DBMET03076 | |
| 0.023 | 0.157 | 0.05 | Vanilloid 3 antagonist | 0.05 0.008 DBMET00552 0.038 0.026 DBMET03077 | DBMET00552 | |
| 0.011 | 0.146 | 0.034 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET00552 0.03 0.023 DBMET03077 | DBMET00552 | |
| 0.043 | 0.178 | 0.094 | Peroxisome proliferator-activated receptor gamma antagonist | 0.094 0.019 DBMET00552 | DBMET00552 | |
| 0.006 | 0.145 | 0.094 | Sphingosine 1-phosphate receptor 3 agonist | 0.06 0.012 DBMET03075 0.055 0.014 DBMET00552 0.068 0.01 DBMET03076 0.094 0.007 DBMET03077 | DBMET03077 | |
| 0.026 | 0.165 | 0.134 | Carbonic anhydrase stimulant | 0.134 0.012 DBMET00552 | DBMET00552 | |
| 0.015 | 0.156 | 0.194 | Glutamate (mGluR3) antagonist | 0.194 0.003 DBMET00552 | DBMET00552 | |
| 0.007 | 0.148 | 0.082 | Kynurenine 3 monooxygenase inhibitor | 0.037 0.011 DBMET03075 0.082 0.004 DBMET00552 | DBMET00552 | |
| 0.007 | 0.15 | 0.03 | 5-Alpha-reductase 2 inhibitor | 0.03 0.009 DBMET00552 | DBMET00552 | |
| 0.005 | 0.152 | 0.046 | Retinoic acid alpha receptor antagonist | 0.046 0.004 DBMET00552 | DBMET00552 | |
| 0.011 | 0.159 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | 0.059 0.013 DBMET03075 0.062 0.012 DBMET00552 0.049 0.021 DBMET03076 0.06 0.013 DBMET03077 | DBMET00552 | |
| 0.006 | 0.154 | 0.038 | Thyroid hormone alpha agonist | 0.038 0.003 DBMET00552 | DBMET00552 | |
| 0.032 | 0.183 | 0.117 | Calcium antagonist | 0.108 0.042 DBMET00552 0.09 0.055 DBMET03076 0.117 0.037 DBMET03077 | DBMET03077 | |
| 0.008 | 0.16 | 0.066 | 5-Alpha-reductase inhibitor | 0.066 0.014 DBMET00552 | DBMET00552 | |
| 0.002 | 0.156 | 0.012 | Integrin alphaVbeta5 antagonist | 0.012 0.006 DBMET00552 | DBMET00552 | |
| 0.011 | 0.166 | 0.08 | Peroxisome proliferator-activated receptor alpha agonist | 0.08 0.017 DBMET00552 | DBMET00552 | |
| 0.004 | 0.162 | 0.024 | 5-Alpha-reductase 1 inhibitor | 0.024 0.01 DBMET00552 | DBMET00552 | |
| 0.078 | 0.236 | 0.282 | DNA methyltransferase I inhibitor | 0.162 0.092 DBMET03075 0.282 0.033 DBMET00552 0.179 0.081 DBMET03076 0.201 0.069 DBMET03077 | DBMET00552 | |
| 0.036 | 0.194 | 0.093 | Myeloperoxidase inhibitor | 0.093 0.045 DBMET00552 | DBMET00552 | |
| 0.012 | 0.17 | 0.054 | Alpha 1d adrenoreceptor agonist | 0.054 0.014 DBMET00552 | DBMET00552 | |
| 0.049 | 0.209 | 0.161 | Interleukin 1 beta converting enzyme inhibitor | 0.161 0.013 DBMET00552 0.126 0.03 DBMET03076 | DBMET00552 | |
| 0.001 | 0.162 | 0.012 | Carboxypeptidase B2 inhibitor | 0.012 0.007 DBMET00552 | DBMET00552 | |
| 0.011 | 0.172 | 0.091 | NMDA receptor subunit 3A antagonist | 0.091 0.009 DBMET00552 | DBMET00552 | |
| 0.009 | 0.171 | 0.025 | Bradykinin B2 receptor agonist | 0.025 0.024 DBMET00552 | DBMET00552 | |
| 0.014 | 0.177 | 0.046 | Carboxypeptidase B inhibitor | 0.046 0.009 DBMET00552 | DBMET00552 | |
| 0.023 | 0.186 | 0.07 | Dopamine beta hydroxylase inhibitor | 0.07 0.008 DBMET00552 | DBMET00552 | |
| 0.011 | 0.175 | 0.107 | Glutamate (mGluR1) agonist | 0.107 0.004 DBMET00552 | DBMET00552 | |
| 0.008 | 0.172 | 0.036 | Diamine oxidase inhibitor | 0.036 0.028 DBMET00552 | DBMET00552 | |
| 0.103 | 0.269 | 0.245 | DNA damaging | 0.245 0.083 DBMET00552 | DBMET00552 | |
| 0.011 | 0.179 | 0.053 | Integrin alpha2beta1 antagonist | 0.053 0.004 DBMET00552 | DBMET00552 | |
| 0.014 | 0.182 | 0.082 | Thymidylate synthase inhibitor | 0.082 0.007 DBMET00552 | DBMET00552 | |
| 0.008 | 0.176 | 0.041 | Prostaglandin EP4 antagonist | 0.041 0.01 DBMET00552 | DBMET00552 | |
| 0.007 | 0.176 | 0.056 | Peroxisome proliferator-activated receptor delta agonist | 0.056 0.011 DBMET00552 | DBMET00552 | |
| 0.001 | 0.17 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET00552 | DBMET00552 | |
| 0.01 | 0.18 | 0.074 | Geranyltranstransferase inhibitor | 0.074 0.006 DBMET00552 0.049 0.024 DBMET03076 | DBMET00552 | |
| 0.073 | 0.244 | 0.253 | Hexokinase inhibitor | 0.233 0.021 DBMET03075 0.222 0.025 DBMET00552 0.253 0.016 DBMET03076 0.202 0.034 DBMET03077 | DBMET03076 | |
| 0.028 | 0.2 | 0.124 | Phospholipase D inhibitor | 0.124 0.005 DBMET00552 0.074 0.045 DBMET03077 | DBMET00552 | |
| 0.087 | 0.259 | 0.16 | Pregnane X receptor agonist | 0.16 0.038 DBMET00552 | DBMET00552 | |
| 0.023 | 0.195 | 0.062 | Aldosterone antagonist | 0.062 0.018 DBMET00552 0.045 0.038 DBMET03077 | DBMET00552 | |
| 0.016 | 0.19 | 0.069 | Tryptophan 5 hydroxylase inhibitor | 0.069 0.003 DBMET00552 | DBMET00552 | |
| 0.008 | 0.181 | 0.085 | Urate transporter 1 inhibitor | 0.085 0.007 DBMET00552 | DBMET00552 | |
| 0.025 | 0.199 | 0.072 | Botulinum neurotoxin type A inhibitor | 0.072 0.023 DBMET00552 | DBMET00552 | |
| 0.114 | 0.288 | 0.346 | Gastrin inhibitor | 0.265 0.063 DBMET03075 0.346 0.011 DBMET00552 0.24 0.092 DBMET03076 0.318 0.022 DBMET03077 | DBMET00552 | |
| 0.001 | 0.177 | 0.013 | Integrin alpha5beta6 antagonist | 0.013 0.003 DBMET00552 | DBMET00552 | |
| 0.005 | 0.181 | 0.046 | Squalene synthetase inhibitor | 0.046 0.016 DBMET00552 | DBMET00552 | |
| 0.013 | 0.192 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.02 DBMET00552 | DBMET00552 | |
| 0.007 | 0.186 | 0.073 | Free fatty acid receptor 1 antagonist | 0.073 0.004 DBMET00552 | DBMET00552 | |
| 0.076 | 0.255 | 0.186 | Sphingosine 1-phosphate receptor 2 antagonist | 0.117 0.105 DBMET03075 0.186 0.012 DBMET00552 0.116 0.107 DBMET03076 0.14 0.056 DBMET03077 | DBMET00552 | |
| 0.102 | 0.281 | 0.252 | Neurotensin receptor agonist | 0.252 0.021 DBMET00552 | DBMET00552 | |
| 0.009 | 0.191 | 0.036 | Nicotinic acid receptor 2 agonist | 0.036 0.024 DBMET00552 | DBMET00552 | |
| 0.054 | 0.239 | 0.127 | Hematopoietic | 0.107 0.03 DBMET03075 0.127 0.019 DBMET00552 | DBMET00552 | |
| 0.032 | 0.217 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.103 0.012 DBMET00552 | DBMET00552 | |
| 0.045 | 0.231 | 0.107 | MDM2 inhibitor | 0.082 0.018 DBMET03075 0.107 0.005 DBMET00552 0.068 0.044 DBMET03076 0.094 0.009 DBMET03077 | DBMET00552 | |
| 0.059 | 0.244 | 0.165 | TRPA1 agonist | 0.165 0.022 DBMET00552 0.156 0.027 DBMET03076 0.105 0.079 DBMET03077 | DBMET00552 | |
| 0.01 | 0.196 | 0.024 | Acid ceramidase inhibitor | 0.024 0.023 DBMET00552 | DBMET00552 | |
| 0.012 | 0.198 | 0.306 | Prostaglandin EP2 antagonist | 0.063 0.038 DBMET03075 0.306 0.004 DBMET00552 | DBMET00552 | |
| 0.132 | 0.318 | 0.225 | 5 Hydroxytryptamine 3E antagonist | 0.225 0.031 DBMET00552 0.183 0.098 DBMET03076 0.188 0.086 DBMET03077 | DBMET00552 | |
| 0.008 | 0.195 | 0.051 | Liver X receptor beta antagonist | 0.051 0.008 DBMET00552 | DBMET00552 | |
| 0.012 | 0.2 | 0.095 | NMDA 2C receptor antagonist | 0.095 0.017 DBMET00552 | DBMET00552 | |
| 0.015 | 0.202 | 0.103 | NMDA receptor subunit 3B antagonist | 0.103 0.01 DBMET00552 | DBMET00552 | |
| 0.09 | 0.278 | 0.39 | Lipocortins synthesis antagonist | 0.39 0.009 DBMET03075 0.358 0.013 DBMET00552 0.15 0.105 DBMET03076 0.19 0.063 DBMET03077 | DBMET03075 | |
| 0.027 | 0.215 | 0.134 | Prostaglandin F2 alpha antagonist | 0.075 0.027 DBMET03075 0.134 0.005 DBMET00552 0.056 0.055 DBMET03076 0.073 0.029 DBMET03077 | DBMET00552 | |
| 0.074 | 0.268 | 0.271 | DNA methylase inhibitor | 0.152 0.115 DBMET03075 0.271 0.038 DBMET00552 0.169 0.102 DBMET03076 0.192 0.085 DBMET03077 | DBMET00552 | |
| 0.072 | 0.267 | 0.348 | Interleukin antagonist | 0.172 0.102 DBMET00552 0.348 0.039 DBMET03077 | DBMET03077 | |
| 0.056 | 0.252 | 0.139 | NADPH oxidase inhibitor | 0.139 0.063 DBMET00552 | DBMET00552 | |
| 0.003 | 0.2 | 0.025 | Egl nine homolog 3 inhibitor | 0.025 0.004 DBMET00552 | DBMET00552 | |
| 0.025 | 0.225 | 0.132 | Androgen antagonist | 0.132 0.028 DBMET00552 0.075 0.072 DBMET03076 0.082 0.063 DBMET03077 | DBMET00552 | |
| 0.02 | 0.223 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | 0.078 0.018 DBMET00552 0.059 0.04 DBMET03077 | DBMET00552 | |
| 0.047 | 0.252 | 0.272 | Bone formation stimulant | 0.272 0.021 DBMET00552 0.177 0.043 DBMET03076 | DBMET00552 | |
| 0.009 | 0.214 | 0.062 | Purinergic P2Y antagonist | 0.062 0.018 DBMET00552 | DBMET00552 | |
| 0.007 | 0.214 | 0.055 | Farnesoid X receptor agonist | 0.055 0.012 DBMET00552 | DBMET00552 | |
| 0.01 | 0.218 | 0.077 | NMDA 2A receptor antagonist | 0.077 0.021 DBMET00552 | DBMET00552 | |
| 0.033 | 0.241 | 0.131 | Glycogen synthase kinase-3 beta inhibitor | 0.131 0.054 DBMET03074 | DBMET03074 | |
| 0.041 | 0.25 | 0.074 | Calcium channel P-type blocker | 0.073 0.023 DBMET00552 0.063 0.045 DBMET03076 0.074 0.022 DBMET03077 | DBMET03077 | |
| 0.052 | 0.263 | 0.198 | Cathepsin H inhibitor | 0.124 0.07 DBMET03075 0.19 0.025 DBMET00552 0.198 0.023 DBMET03076 0.153 0.044 DBMET03077 | DBMET03076 | |
| 0.008 | 0.219 | 0.043 | Carbonic anhydrase VII inhibitor | 0.043 0.037 DBMET00552 | DBMET00552 | |
| 0.035 | 0.247 | 0.072 | Phosphodiesterase VI inhibitor | 0.072 0.056 DBMET03077 | DBMET03077 | |
| 0.053 | 0.265 | 0.152 | Glutamate (mGluR7) agonist | 0.152 0.011 DBMET00552 | DBMET00552 | |
| 0.014 | 0.226 | 0.071 | Integrin alpha2 antagonist | 0.071 0.005 DBMET00552 | DBMET00552 | |
| 0.006 | 0.22 | 0.052 | Glucagon receptor antagonist | 0.052 0.01 DBMET00552 | DBMET00552 | |
| 0.013 | 0.228 | 0.066 | Sphingosine 1-phosphate receptor agonist | 0.057 0.019 DBMET03075 0.066 0.013 DBMET00552 0.045 0.03 DBMET03076 0.058 0.018 DBMET03077 | DBMET00552 | |
| 0.07 | 0.288 | 0.19 | P-glycoprotein inhibitor | 0.149 0.119 DBMET03076 0.19 0.071 DBMET03077 | DBMET03077 | |
| 0.008 | 0.226 | 0.041 | LFA antagonist | 0.041 0.007 DBMET00552 | DBMET00552 | |
| 0.083 | 0.302 | 0.206 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.066 DBMET03075 0.206 0.009 DBMET00552 0.143 0.074 DBMET03076 0.168 0.035 DBMET03077 | DBMET00552 | |
| 0.005 | 0.224 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DBMET00552 | DBMET00552 | |
| 0.005 | 0.228 | 0.045 | HCV NS5B polymerase inhibitor | 0.045 0.012 DBMET00552 | DBMET00552 | |
| 0.021 | 0.246 | 0.13 | Glutamate (mGluR group III) antagonist | 0.13 0.004 DBMET00552 | DBMET00552 | |
| 0.005 | 0.23 | 0.063 | Carbonic anhydrase IV inhibitor | 0.063 0.018 DBMET00552 | DBMET00552 | |
| 0.024 | 0.251 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | 0.057 0.03 DBMET00552 | DBMET00552 | |
| 0.077 | 0.304 | 0.194 | CF transmembrane conductance regulator agonist | 0.194 0.025 DBMET00552 | DBMET00552 | |
| 0.011 | 0.238 | 0.05 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET00799 0.05 0.024 DBMET00552 | DBMET00552 | |
| 0.004 | 0.231 | 0.04 | NMDA receptor glycine site antagonist | 0.04 0.008 DBMET00552 | DBMET00552 | |
| 0.046 | 0.274 | 0.083 | Thioredoxin reductase inhibitor | 0.083 0.053 DBMET03076 | DBMET03076 | |
| 0.067 | 0.295 | 0.334 | Platelet adhesion inhibitor | 0.334 0.024 DBMET00799 0.306 0.032 DBMET00552 | DBMET00799 | |
| 0.056 | 0.283 | 0.174 | Interleukin 8 antagonist | 0.174 0.022 DBMET00552 | DBMET00552 | |
| 0.004 | 0.232 | 0.031 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.031 0.007 DBMET00552 | DBMET00552 | |
| 0.026 | 0.253 | 0.058 | Heat shock protein 90 beta antagonist | 0.058 0.043 DBMET00552 | DBMET00552 | |
| 0.035 | 0.263 | 0.126 | Chymotrypsin inhibitor | 0.126 0.023 DBMET03076 | DBMET03076 | |
| 0.011 | 0.24 | 0.056 | RNA-directed RNA polymerase inhibitor | 0.032 0.027 DBMET03075 0.056 0.011 DBMET00552 | DBMET00552 | |
| 0.115 | 0.344 | 0.369 | Insulysin inhibitor | 0.237 0.109 DBMET03075 0.369 0.028 DBMET00552 0.232 0.115 DBMET03076 0.253 0.094 DBMET03077 | DBMET00552 | |
| 0.009 | 0.239 | 0.046 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.046 0.011 DBMET00552 0.034 0.024 DBMET03077 | DBMET00552 | |
| 0.006 | 0.237 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.041 0.011 DBMET00552 0.03 0.026 DBMET03077 | DBMET00552 | |
| 0.018 | 0.251 | 0.115 | VCAM-1 antagonist | 0.039 0.029 DBMET03075 0.115 0.004 DBMET00552 | DBMET00552 | |
| 0.018 | 0.252 | 0.118 | VCAM antagonist | 0.043 0.018 DBMET03075 0.118 0.004 DBMET00552 | DBMET00552 | |
| 0.014 | 0.248 | 0.055 | Prolyl endopeptidase inhibitor | 0.055 0.03 DBMET00552 | DBMET00552 | |
| 0.015 | 0.251 | 0.096 | Glucagon-like peptide 1 agonist | 0.096 0.024 DBMET00552 | DBMET00552 | |
| 0.014 | 0.252 | 0.07 | Dihydroorotase inhibitor | 0.07 0.012 DBMET00552 | DBMET00552 | |
| 0.002 | 0.242 | 0.018 | Integrin beta2 antagonist | 0.018 0.005 DBMET00552 | DBMET00552 | |
| 0.033 | 0.273 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 DBMET00552 0.053 0.045 DBMET03076 0.06 0.024 DBMET03077 | DBMET00552 | |
| 0.051 | 0.292 | 0.133 | Acetylcholine release stimulant | 0.133 0.031 DBMET00552 0.102 0.084 DBMET03077 | DBMET00552 | |
| 0.013 | 0.256 | 0.036 | Melatonin receptor 1A agonist | 0.036 0.019 DBMET00552 | DBMET00552 | |
| 0.018 | 0.261 | 0.069 | GABA B receptor antagonist | 0.069 0.009 DBMET00552 | DBMET00552 | |
| 0.046 | 0.29 | 0.245 | Neurotrophic factor | 0.245 0.013 DBMET03076 0.144 0.065 DBMET03077 | DBMET03076 | |
| 0.046 | 0.29 | 0.08 | Vanilloid agonist | 0.08 0.071 DBMET00552 | DBMET00552 | |
| 0.02 | 0.265 | 0.132 | Glutamate (mGluR4) antagonist | 0.132 0.004 DBMET00552 | DBMET00552 | |
| 0.18 | 0.426 | 0.51 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.51 0.029 DBMET00552 0.339 0.164 DBMET03076 0.348 0.153 DBMET03077 | DBMET00552 | |
| 0.039 | 0.285 | 0.138 | Alkaline phosphatase inhibitor | 0.138 0.069 DBMET00552 | DBMET00552 | |
| 0.02 | 0.269 | 0.095 | CYP2A6 inhibitor | 0.095 0.038 DBMET00552 | DBMET00552 | |
| 0.12 | 0.369 | 0.383 | Caspase 3 stimulant | 0.383 0.049 DBMET03076 | DBMET03076 | |
| 0.003 | 0.253 | 0.025 | Egl nine homolog 1 inhibitor | 0.025 0.005 DBMET00552 | DBMET00552 | |
| 0.028 | 0.28 | 0.172 | Falcipain 3 inhibitor | 0.154 0.035 DBMET00552 0.172 0.027 DBMET03076 0.152 0.035 DBMET03077 | DBMET03076 | |
| 0.014 | 0.266 | 0.043 | Protein kinase (CK2) beta inhibitor | 0.043 0.01 DBMET00552 | DBMET00552 | |
| 0.027 | 0.28 | 0.123 | Histamine N-methyltransferase inhibitor | 0.123 0.028 DBMET00552 | DBMET00552 | |
| 0.028 | 0.281 | 0.188 | Protease inhibitor | 0.101 0.064 DBMET03075 0.182 0.019 DBMET03076 0.188 0.017 DBMET03077 | DBMET03077 | |
| 0.008 | 0.263 | 0.036 | Plasmepsin I inhibitor | 0.036 0.015 DBMET03076 0.031 0.02 DBMET03077 | DBMET03076 | |
| 0.021 | 0.277 | 0.072 | Sphingosine 1-phosphate receptor 1 antagonist | 0.072 0.017 DBMET00552 0.072 0.017 DBMET03077 | DBMET03077 | |
| 0.006 | 0.267 | 0.029 | Integrin beta6 antagonist | 0.029 0.003 DBMET00552 | DBMET00552 | |
| 0.012 | 0.274 | 0.102 | AMPA 4 receptor antagonist | 0.102 0.005 DBMET00552 | DBMET00552 | |
| 0.017 | 0.281 | 0.111 | Glutamate (mGluR8) antagonist | 0.111 0.002 DBMET00552 | DBMET00552 | |
| 0.082 | 0.348 | 0.15 | MAP kinase kinase 4 inhibitor | 0.138 0.09 DBMET03076 0.15 0.062 DBMET03077 | DBMET03077 | |
| 0.011 | 0.278 | 0.029 | Complement factor 1s inhibitor | 0.029 0.01 DBMET00552 | DBMET00552 | |
| 0.01 | 0.278 | 0.075 | Neutrophil collagenase inhibitor | 0.075 0.035 DBMET00552 | DBMET00552 | |
| 0.006 | 0.276 | 0.036 | DNA gyrase subunit B inhibitor | 0.036 0.029 DBMET00552 | DBMET00552 | |
| 0.021 | 0.291 | 0.075 | Metalloproteinase-9 inhibitor | 0.075 0.048 DBMET00552 | DBMET00552 | |
| 0.012 | 0.282 | 0.078 | Acetylcholine M5 receptor agonist | 0.078 0.036 DBMET00552 | DBMET00552 | |
| 0.067 | 0.341 | 0.246 | 3C-like protease (Human coronavirus) inhibitor | 0.214 0.044 DBMET00552 0.246 0.029 DBMET03076 0.221 0.041 DBMET03077 | DBMET03076 | |
| 0.004 | 0.282 | 0.03 | Glutamate (mGluR2) antagonist | 0.03 0.019 DBMET00552 | DBMET00552 | |
| 0.005 | 0.283 | 0.052 | Glutamate (mGluR group II) antagonist | 0.052 0.014 DBMET00552 | DBMET00552 | |
| 0.005 | 0.287 | 0.064 | Leukotriene D4 antagonist | 0.064 0.008 DBMET00552 | DBMET00552 | |
| 0.024 | 0.307 | 0.096 | Glycogen synthase kinase-3 inhibitor | 0.096 0.083 DBMET03074 | DBMET03074 | |
| 0.002 | 0.285 | 0.047 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.047 0.004 DBMET00552 | DBMET00552 | |
| 0.006 | 0.292 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 DBMET00552 | DBMET00552 | |
| 0.023 | 0.31 | 0.169 | Potassium channel (Ca-activated) activator | 0.169 0.022 DBMET00552 | DBMET00552 | |
| 0.013 | 0.301 | 0.057 | Matrix metalloproteinase (membrane-type) inhibitor | 0.057 0.035 DBMET00552 | DBMET00552 | |
| 0.073 | 0.362 | 0.185 | Thyroid hormone antagonist | 0.185 0.175 DBMET00552 | DBMET00552 | |
| 0.016 | 0.306 | 0.034 | Adenosine uptake inhibitor | 0.034 0.026 DBMET00552 | DBMET00552 | |
| 0.005 | 0.296 | 0.066 | Fructose-1,6-bisphosphatase inhibitor | 0.066 0.014 DBMET00552 | DBMET00552 | |
| 0.009 | 0.302 | 0.061 | Glycine transporter 2 inhibitor | 0.061 0.025 DBMET00552 | DBMET00552 | |
| 0.007 | 0.301 | 0.051 | Retinoid X gamma receptor antagonist | 0.051 0.003 DBMET00552 | DBMET00552 | |
| 0.026 | 0.321 | 0.105 | Caspase 7 inhibitor | 0.105 0.023 DBMET00552 0.085 0.051 DBMET03076 | DBMET00552 | |
| 0.005 | 0.3 | 0.047 | Carnitine palmitoyltransferase 1 inhibitor | 0.047 0.009 DBMET00552 | DBMET00552 | |
| 0.075 | 0.372 | 0.221 | 12-Lipoxygenase inhibitor | 0.221 0.13 DBMET00552 | DBMET00552 | |
| 0.011 | 0.31 | 0.055 | Liver X receptor alpha agonist | 0.055 0.015 DBMET00552 | DBMET00552 | |
| 0.052 | 0.352 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.136 0.048 DBMET03075 0.178 0.015 DBMET00552 0.15 0.033 DBMET03076 0.165 0.022 DBMET03077 | DBMET00552 | |
| 0.013 | 0.313 | 0.09 | Diacylglycerol O-acyltransferase inhibitor | 0.09 0.01 DBMET00552 | DBMET00552 | |
| 0.006 | 0.307 | 0.022 | CXC chemokine 5 receptor antagonist | 0.022 0.006 DBMET00552 | DBMET00552 | |
| 0.011 | 0.313 | 0.041 | Glutamate (mGluR1a) antagonist | 0.041 0.029 DBMET00552 | DBMET00552 | |
| 0.005 | 0.307 | 0.048 | Carnitine palmitoyltransferase inhibitor | 0.048 0.009 DBMET00552 | DBMET00552 | |
| 0.062 | 0.365 | 0.387 | Growth hormone agonist | 0.139 0.097 DBMET03075 0.387 0.018 DBMET00552 | DBMET00552 | |
| 0.025 | 0.328 | 0.17 | DNA helicase inhibitor | 0.17 0.003 DBMET00552 | DBMET00552 | |
| 0.063 | 0.366 | 0.142 | MAP kinase 3 inhibitor | 0.142 0.081 DBMET00552 0.127 0.115 DBMET03077 | DBMET00552 | |
| 0.007 | 0.31 | 0.039 | Peptide deformylase inhibitor | 0.039 0.015 DBMET00552 | DBMET00552 | |
| 0.01 | 0.313 | 0.065 | Nerve growth factor antagonist | 0.065 0.007 DBMET00552 | DBMET00552 | |
| 0.024 | 0.328 | 0.09 | Protein kinase C zeta inhibitor | 0.09 0.065 DBMET00552 | DBMET00552 | |
| 0.058 | 0.363 | 0.126 | NOS3 expression enhancer | 0.126 0.105 DBMET00552 | DBMET00552 | |
| 0.042 | 0.351 | 0.482 | Cell adhesion inhibitor | 0.482 0.004 DBMET00552 | DBMET00552 | |
| 0.002 | 0.313 | 0.059 | Kainate receptor 1 antagonist | 0.059 0.005 DBMET00552 | DBMET00552 | |
| 0.005 | 0.319 | 0.038 | Liver X receptor beta agonist | 0.038 0.017 DBMET00552 | DBMET00552 | |
| 0.004 | 0.318 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.016 DBMET00552 | DBMET00552 | |
| 0.012 | 0.326 | 0.046 | MAP3K5 inhibitor | 0.046 0.017 DBMET00552 | DBMET00552 | |
| 0.013 | 0.331 | 0.105 | NMDA receptor antagonist | 0.105 0.044 DBMET00552 | DBMET00552 | |
| 0.036 | 0.354 | 0.354 | Pyruvate kinase inhibitor | 0.235 0.066 DBMET03075 0.354 0.032 DBMET00552 0.135 0.13 DBMET03076 0.149 0.116 DBMET03077 | DBMET00552 | |
| 0.051 | 0.37 | 0.151 | Antiamyloidogenic | 0.151 0.146 DBMET00552 | DBMET00552 | |
| 0.012 | 0.332 | 0.067 | Matrix metalloproteinase inhibitor | 0.067 0.047 DBMET00552 | DBMET00552 | |
| 0.004 | 0.325 | 0.082 | Thyroid hormone alpha antagonist | 0.082 0.004 DBMET00552 | DBMET00552 | |
| 0.003 | 0.325 | 0.196 | Free fatty acid receptor 1 agonist | 0.196 0.003 DBMET00552 | DBMET00552 | |
| 0.003 | 0.327 | 0.105 | Integrin beta7 antagonist | 0.105 0.004 DBMET00552 | DBMET00552 | |
| 0.025 | 0.35 | 0.131 | MAP kinase kinase inhibitor | 0.11 0.084 DBMET03076 0.131 0.064 DBMET03077 | DBMET03077 | |
| 0.017 | 0.343 | 0.088 | Metalloproteinase-2 inhibitor | 0.088 0.046 DBMET00552 | DBMET00552 | |
| 0.049 | 0.376 | 0.174 | Thiol protease inhibitor | 0.162 0.06 DBMET00552 0.174 0.052 DBMET03076 | DBMET03076 | |
| 0.008 | 0.335 | 0.052 | Metalloproteinase-3 inhibitor | 0.052 0.031 DBMET00552 | DBMET00552 | |
| 0.009 | 0.34 | 0.047 | Dihydroorotate dehydrogenase inhibitor | 0.047 0.041 DBMET00552 | DBMET00552 | |
| 0.004 | 0.338 | 0.028 | Methionyl aminopeptidase 2 inhibitor | 0.028 0.015 DBMET00552 | DBMET00552 | |
| 0.005 | 0.34 | 0.053 | Carbonic anhydrase inhibitor | 0.053 0.052 DBMET00552 | DBMET00552 | |
| 0.006 | 0.343 | 0.023 | Geranylgeranyltransferase inhibitor | 0.023 0.014 DBMET00552 | DBMET00552 | |
| 0.01 | 0.35 | 0.213 | Plasminogen activator inhibitor antagonist | 0.213 0.004 DBMET00552 | DBMET00552 | |
| 0.031 | 0.372 | 0.164 | Cytidine deaminase inhibitor | 0.164 0.066 DBMET00552 | DBMET00552 | |
| 0.018 | 0.36 | 0.068 | Secretase beta inhibitor | 0.067 0.055 DBMET00552 0.068 0.053 DBMET03077 | DBMET03077 | |
| 0.004 | 0.346 | 0.099 | Kainate receptor 2 antagonist | 0.099 0.005 DBMET00552 | DBMET00552 | |
| 0.013 | 0.356 | 0.062 | HCV NS3/NS4A protease inhibitor | 0.062 0.019 DBMET00552 | DBMET00552 | |
| 0.004 | 0.348 | 0.029 | Nicotinic alpha3beta4 receptor agonist | 0.029 0.023 DBMET00552 | DBMET00552 | |
| 0.011 | 0.356 | 0.074 | Glutamate (mGluR4) agonist | 0.074 0.006 DBMET00552 | DBMET00552 | |
| 0.011 | 0.359 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.058 DBMET00552 | DBMET00552 | |
| 0.025 | 0.373 | 0.068 | Adenosine A3 receptor antagonist | 0.068 0.063 DBMET00552 | DBMET00552 | |
| 0.002 | 0.351 | 0.018 | Angiotensin AT1B receptor antagonist | 0.018 0.007 DBMET00552 | DBMET00552 | |
| 0.021 | 0.371 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.044 DBMET00552 | DBMET00552 | |
| 0.009 | 0.359 | 0.368 | Peroxisome proliferator-activated receptor gamma agonist | 0.368 0.004 DBMET00552 | DBMET00552 | |
| 0.014 | 0.365 | 0.133 | Glutamate (mGluR group III) agonist | 0.133 0.006 DBMET00552 | DBMET00552 | |
| 0.004 | 0.36 | 0.049 | Carbonic anhydrase I inhibitor | 0.049 0.044 DBMET00552 | DBMET00552 | |
| 0.018 | 0.376 | 0.06 | 5 Hydroxytryptamine 3 agonist | 0.06 0.049 DBMET00552 | DBMET00552 | |
| 0.007 | 0.368 | 0.077 | NMDA 2D receptor antagonist | 0.077 0.004 DBMET00799 0.059 0.005 DBMET00552 | DBMET00799 | |
| 0.034 | 0.396 | 0.195 | MAP kinase kinase 2 inhibitor | 0.161 0.111 DBMET00552 0.195 0.085 DBMET03077 | DBMET03077 | |
| 0.028 | 0.393 | 0.174 | Aryl hydrocarbon receptor agonist | 0.174 0.118 DBMET00552 | DBMET00552 | |
| 0.015 | 0.379 | 0.055 | Cyclin D1 inhibitor | 0.055 0.052 DBMET00552 | DBMET00552 | |
| 0.004 | 0.37 | 0.056 | AMPA 3 receptor antagonist | 0.056 0.007 DBMET00552 | DBMET00552 | |
| 0.007 | 0.374 | 0.045 | Angiotensin II receptor antagonist | 0.045 0.009 DBMET00552 | DBMET00552 | |
| 0.003 | 0.371 | 0.027 | Endothelin B receptor antagonist | 0.027 0.01 DBMET00552 | DBMET00552 | |
| 0.005 | 0.375 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.009 DBMET00552 | DBMET00552 | |
| 0.004 | 0.376 | 0.152 | Retinoid X beta receptor agonist | 0.152 0.003 DBMET00552 | DBMET00552 | |
| 0.022 | 0.395 | 0.09 | Sphingosine 1-phosphate receptor antagonist | 0.09 0.03 DBMET00552 0.087 0.034 DBMET03077 | DBMET00552 | |
| 0.012 | 0.385 | 0.105 | Angiotensin-converting enzyme inhibitor | 0.105 0.008 DBMET00552 | DBMET00552 | |
| 0.003 | 0.377 | 0.02 | Complement factor D inhibitor | 0.02 0.009 DBMET00552 | DBMET00552 | |
| 0.048 | 0.422 | 0.221 | Folate antagonist | 0.221 0.007 DBMET00552 | DBMET00552 | |
| 0.004 | 0.378 | 0.041 | G protein-coupled receptor agonist | 0.041 0.024 DBMET00552 | DBMET00552 | |
| 0.002 | 0.378 | 0.014 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.006 DBMET00552 | DBMET00552 | |
| 0.009 | 0.386 | 0.046 | Histamine H2 receptor agonist | 0.046 0.026 DBMET00552 | DBMET00552 | |
| 0.004 | 0.382 | 0.106 | Kainate receptor antagonist | 0.106 0.007 DBMET00552 | DBMET00552 | |
| 0.001 | 0.383 | 0.009 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.009 0.004 DBMET00552 | DBMET00552 | |
| 0.008 | 0.391 | 0.038 | Caspase 6 inhibitor | 0.038 0.009 DBMET00552 0.037 0.01 DBMET03076 | DBMET00552 | |
| 0.002 | 0.39 | 0.053 | AMPA 1 receptor antagonist | 0.053 0.01 DBMET00552 | DBMET00552 | |
| 0.044 | 0.436 | 0.092 | CC chemokine 5 receptor agonist | 0.092 0.032 DBMET00552 | DBMET00552 | |
| 0.056 | 0.455 | 0.236 | Transcription factor STAT3 inhibitor | 0.236 0.095 DBMET00552 0.204 0.128 DBMET03076 | DBMET00552 | |
| 0.06 | 0.461 | 0.231 | 15-Lipoxygenase inhibitor | 0.231 0.182 DBMET00552 | DBMET00552 | |
| 0.005 | 0.406 | 0.028 | MAP3K8 inhibitor | 0.028 0.023 DBMET00552 | DBMET00552 | |
| 0.024 | 0.425 | 0.294 | Uric acid excretion stimulant | 0.294 0.005 DBMET00552 | DBMET00552 | |
| 0.005 | 0.407 | 0.039 | Epoxide hydrolase 1 inhibitor | 0.039 0.012 DBMET00552 | DBMET00552 | |
| 0.004 | 0.407 | 0.064 | NMDA 2 receptor antagonist | 0.064 0.058 DBMET00552 | DBMET00552 | |
| 0.015 | 0.42 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | 0.074 0.022 DBMET00552 | DBMET00552 | |
| 0.028 | 0.437 | 0.131 | Beta amyloid protein antagonist | 0.131 0.056 DBMET00552 | DBMET00552 | |
| 0.029 | 0.44 | 0.088 | Bromodomain-containing protein 2 inhibitor | 0.088 0.058 DBMET00552 | DBMET00552 | |
| 0.059 | 0.476 | 0.226 | Neuropeptide Y2 antagonist | 0.226 0.081 DBMET00552 0.175 0.171 DBMET03077 | DBMET00552 | |
| 0.007 | 0.427 | 0.031 | Tryptophan hydroxylase 1 inhibitor | 0.031 0.003 DBMET00552 | DBMET00552 | |
| 0.005 | 0.429 | 0.244 | Peroxisome proliferator-activated receptor delta antagonist | 0.244 0.004 DBMET00552 | DBMET00552 | |
| 0.022 | 0.447 | 0.058 | Phosphodiesterase 1C inhibitor | 0.058 0.054 DBMET00552 | DBMET00552 | |
| 0.031 | 0.456 | 0.21 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.21 0.094 DBMET00552 | DBMET00552 | |
| 0.03 | 0.459 | 0.329 | Interleukin 1b antagonist | 0.137 0.049 DBMET03076 0.329 0.007 DBMET03077 | DBMET03077 | |
| 0.004 | 0.435 | 0.241 | Prostacyclin antagonist | 0.241 0.003 DBMET00552 | DBMET00552 | |
| 0.016 | 0.451 | 0.075 | Elastase 1 inhibitor | 0.065 0.054 DBMET00552 0.075 0.041 DBMET03076 | DBMET03076 | |
| 0.02 | 0.458 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.142 0.04 DBMET00552 | DBMET00552 | |
| 0.011 | 0.45 | 0.143 | Leukotriene synthesis inhibitor | 0.143 0.01 DBMET00552 | DBMET00552 | |
| 0.003 | 0.442 | 0.026 | Angiotensin-converting enzyme 2 inhibitor | 0.026 0.005 DBMET00552 | DBMET00552 | |
| 0.033 | 0.476 | 0.222 | Calpain inhibitor | 0.221 0.094 DBMET00552 0.222 0.093 DBMET03076 | DBMET03076 | |
| 0.003 | 0.447 | 0.036 | Prostaglandin EP1 antagonist | 0.036 0.009 DBMET00552 | DBMET00552 | |
| 0.045 | 0.489 | 0.147 | Tumour necrosis factor antagonist | 0.147 0.105 DBMET00552 | DBMET00552 | |
| 0.013 | 0.458 | 0.061 | Human rhinovirus A protease inhibitor | 0.061 0.034 DBMET03076 | DBMET03076 | |
| 0.017 | 0.464 | 0.048 | CXC chemokine 1 receptor antagonist | 0.048 0.041 DBMET00552 | DBMET00552 | |
| 0.018 | 0.469 | 0.107 | Gastric antisecretory | 0.102 0.063 DBMET00552 0.107 0.057 DBMET03077 | DBMET03077 | |
| 0.003 | 0.457 | 0.126 | Retinoid X gamma receptor agonist | 0.126 0.003 DBMET00552 | DBMET00552 | |
| 0.014 | 0.468 | 0.079 | Sirtuin 1 inhibitor | 0.079 0.036 DBMET00552 | DBMET00552 | |
| 0.01 | 0.465 | 0.105 | Inducible nitric-oxide synthase inhibitor | 0.105 0.033 DBMET00552 | DBMET00552 | |
| 0.033 | 0.489 | 0.213 | ABCA1 expression enhancer | 0.213 0.008 DBMET00552 0.112 0.037 DBMET03076 | DBMET00552 | |
| 0.002 | 0.462 | 0.021 | 3C-Like protease (MERS coronavirus) inhibitor | 0.021 0.004 DBMET03076 | DBMET03076 | |
| 0.004 | 0.466 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 DBMET00552 | DBMET00552 | |
| 0.002 | 0.468 | 0.023 | Aminopeptidase P inhibitor | 0.023 0.016 DBMET00552 | DBMET00552 | |
| 0.004 | 0.469 | 0.053 | Endothelin receptor antagonist | 0.053 0.01 DBMET00552 | DBMET00552 | |
| 0.007 | 0.475 | 0.098 | Protein kinase (CK2) inhibitor | 0.098 0.065 DBMET00552 | DBMET00552 | |
| 0.013 | 0.483 | 0.046 | CC chemokine 4 receptor antagonist | 0.046 0.035 DBMET00552 | DBMET00552 | |
| 0.006 | 0.475 | 0.049 | Dihydrofolate reductase inhibitor | 0.049 0.021 DBMET00552 | DBMET00552 | |
| 0.004 | 0.476 | 0.101 | Complement C3a chemotactic receptor antagonist | 0.101 0.008 DBMET00552 | DBMET00552 | |
| 0.048 | 0.521 | 0.228 | Transcription factor STAT inhibitor | 0.228 0.104 DBMET00552 | DBMET00552 | |
| 0.04 | 0.514 | 0.283 | Calpain 2 inhibitor | 0.247 0.152 DBMET00552 0.283 0.125 DBMET03076 | DBMET03076 | |
| 0.003 | 0.482 | 0.026 | Endothelin A receptor antagonist | 0.026 0.011 DBMET00552 | DBMET00552 | |
| 0.024 | 0.505 | 0.155 | Caspase 9 inhibitor | 0.071 0.031 DBMET03075 0.155 0.005 DBMET00552 0.154 0.005 DBMET03076 0.061 0.046 DBMET03077 | DBMET00552 | |
| 0.02 | 0.503 | 0.129 | Nav1.6 sodium channel blocker | 0.129 0.083 DBMET00552 | DBMET00552 | |
| 0.012 | 0.496 | 0.063 | Neurotensin receptor antagonist | 0.063 0.023 DBMET00552 | DBMET00552 | |
| 0.003 | 0.489 | 0.299 | GP IIb/IIIa receptor antagonist | 0.299 0.005 DBMET00552 | DBMET00552 | |
| 0.006 | 0.493 | 0.043 | Histamine H1 receptor agonist | 0.043 0.031 DBMET00552 | DBMET00552 | |
| 0.023 | 0.519 | 0.105 | Nav1.3 sodium channel blocker | 0.105 0.092 DBMET03076 | DBMET03076 | |
| 0.017 | 0.515 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.036 DBMET00552 | DBMET00552 | |
| 0.02 | 0.524 | 0.169 | I kappa B kinase epsilon inhibitor | 0.169 0.1 DBMET00552 | DBMET00552 | |
| 0.005 | 0.514 | 0.112 | Protein kinase (CK2) alpha inhibitor | 0.112 0.067 DBMET00552 | DBMET00552 | |
| 0.003 | 0.516 | 0.072 | AMPA receptor antagonist | 0.072 0.02 DBMET00552 | DBMET00552 | |
| 0.03 | 0.543 | 0.208 | 5 Hydroxytryptamine 1E antagonist | 0.208 0.122 DBMET00552 | DBMET00552 | |
| 0.006 | 0.529 | 0.067 | Epoxide hydrolase inhibitor | 0.067 0.058 DBMET00552 | DBMET00552 | |
| 0.032 | 0.556 | 0.159 | Antipruritic | 0.159 0.085 DBMET00552 | DBMET00552 | |
| 0.009 | 0.533 | 0.213 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.043 DBMET03075 0.213 0.004 DBMET00552 | DBMET00552 | |
| 0.004 | 0.531 | 0.077 | Prostaglandin-E synthase inhibitor | 0.077 0.041 DBMET00552 | DBMET00552 | |
| 0.052 | 0.587 | 0.159 | Growth factor agonist | 0.159 0.123 DBMET03076 | DBMET03076 | |
| 0.005 | 0.54 | 0.029 | Dipeptidyl peptidase II inhibitor | 0.029 0.028 DBMET00552 | DBMET00552 | |
| 0.004 | 0.541 | 0.059 | Cathepsin L inhibitor | 0.059 0.039 DBMET03076 | DBMET03076 | |
| 0.026 | 0.565 | 0.128 | Neuropeptide Y1 antagonist | 0.128 0.104 DBMET00552 | DBMET00552 | |
| 0.009 | 0.549 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.02 DBMET00799 0.032 0.025 DBMET00552 | DBMET00799 | |
| 0.012 | 0.552 | 0.107 | Nitric-oxide synthase inhibitor | 0.107 0.05 DBMET00552 | DBMET00552 | |
| 0.002 | 0.555 | 0.062 | Neutral endopeptidase inhibitor | 0.062 0.006 DBMET00552 | DBMET00552 | |
| 0.006 | 0.562 | 0.069 | Collagenase 3 inhibitor | 0.069 0.032 DBMET00552 | DBMET00552 | |
| 0.004 | 0.562 | 0.044 | Glutamate (mGluR5) agonist | 0.044 0.034 DBMET00552 | DBMET00552 | |
| 0.003 | 0.567 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DBMET00552 | DBMET00552 | |
| 0.005 | 0.569 | 0.095 | Prostaglandin E2 antagonist | 0.095 0.015 DBMET00552 | DBMET00552 | |
| 0.018 | 0.584 | 0.11 | Potassium channel large-conductance Ca-activated activator | 0.11 0.02 DBMET00552 | DBMET00552 | |
| 0.003 | 0.57 | 0.023 | Estrone sulfatase inhibitor | 0.023 0.014 DBMET00799 | DBMET00799 | |
| 0.01 | 0.58 | 0.674 | Cholecystokinin B agonist | 0.674 0.001 DBMET00799 0.048 0.017 DBMET00552 | DBMET00799 | |
| 0.003 | 0.581 | 0.181 | VLA-4 antagonist | 0.181 0.004 DBMET00552 | DBMET00552 | |
| 0.012 | 0.593 | 0.115 | GABA receptor agonist | 0.115 0.061 DBMET00552 | DBMET00552 | |
| 0.009 | 0.592 | 0.064 | Aminopeptidase microsomal inhibitor | 0.064 0.036 DBMET00552 | DBMET00552 | |
| 0.005 | 0.59 | 0.051 | Plasmin inhibitor | 0.051 0.032 DBMET03076 | DBMET03076 | |
| 0.014 | 0.605 | 0.056 | Glucagon-like peptide 1 receptor antagonist | 0.056 0.01 DBMET00552 | DBMET00552 | |
| 0.004 | 0.596 | 0.055 | Glutamate (mGluR group I) agonist | 0.055 0.026 DBMET00552 | DBMET00552 | |
| 0.005 | 0.597 | 0.034 | Liver X receptor alpha antagonist | 0.034 0.013 DBMET00552 | DBMET00552 | |
| 0.011 | 0.606 | 0.104 | Carnitine palmitoyltransferase 1B inhibitor | 0.104 0.005 DBMET00552 | DBMET00552 | |
| 0.012 | 0.61 | 0.05 | HCV polyprotein inhibitor | 0.05 0.005 DBMET03075 0.038 0.015 DBMET00552 | DBMET03075 | |
| 0.004 | 0.61 | 0.025 | Purinergic P2Y12 antagonist | 0.025 0.015 DBMET00552 | DBMET00552 | |
| 0.003 | 0.61 | 0.088 | Prostaglandin EP3 antagonist | 0.088 0.006 DBMET00552 | DBMET00552 | |
| 0.005 | 0.633 | 0.127 | Macrophage elastase inhibitor | 0.127 0.007 DBMET00552 | DBMET00552 | |
| 0.004 | 0.633 | 0.106 | Glutamate receptor agonist | 0.106 0.034 DBMET00552 | DBMET00552 | |
| 0.003 | 0.635 | 0.018 | Integrin alphaLbeta2 antagonist | 0.018 0.005 DBMET00552 | DBMET00552 | |
| 0.005 | 0.638 | 0.045 | Aminopeptidase N inhibitor | 0.045 0.036 DBMET00552 | DBMET00552 | |
| 0.003 | 0.638 | 0.123 | Integrin alpha4beta7 antagonist | 0.123 0.003 DBMET00552 | DBMET00552 | |
| 0.004 | 0.654 | 0.139 | Integrin alphaVbeta3 antagonist | 0.139 0.004 DBMET00552 | DBMET00552 | |
| 0.018 | 0.672 | 0.262 | Interleukin 1 antagonist | 0.262 0.017 DBMET03077 | DBMET03077 | |
| 0.004 | 0.664 | 0.133 | Protocollagen prolyl hydroxylase inhibitor | 0.133 0.004 DBMET00552 | DBMET00552 | |
| 0.008 | 0.67 | 0.079 | Adrenaline antagonist | 0.079 0.069 DBMET03077 | DBMET03077 | |
| 0.024 | 0.689 | 0.183 | Histone acetyltransferase inhibitor | 0.183 0.095 DBMET00552 | DBMET00552 | |
| 0.008 | 0.676 | 0.081 | Antiadrenergic | 0.081 0.07 DBMET03077 | DBMET03077 | |
| 0.004 | 0.678 | 0.033 | Liver X receptor antagonist | 0.033 0.02 DBMET00552 | DBMET00552 | |
| 0.003 | 0.677 | 0.157 | Calpain 1 inhibitor | 0.157 0.003 DBMET03076 | DBMET03076 | |
| 0.01 | 0.713 | 0.071 | Histone deacetylase stimulant | 0.071 0.054 DBMET03077 | DBMET03077 | |
| 0.01 | 0.713 | 0.071 | Histone deacetylase SIRT1 stimulant | 0.071 0.054 DBMET03077 | DBMET03077 | |
| 0.003 | 0.71 | 0.295 | Integrin alpha4 antagonist | 0.295 0.004 DBMET00552 | DBMET00552 | |
| 0.003 | 0.717 | 0.073 | Leukotriene A4 hydrolase inhibitor | 0.073 0.01 DBMET00552 | DBMET00552 | |
| 0.004 | 0.728 | 0.518 | Prostaglandin antagonist | 0.518 0.004 DBMET00552 | DBMET00552 | |
| 0.022 | 0.753 | 0.395 | 3C-Like protease (SARS coronavirus) inhibitor | 0.26 0.004 DBMET03076 0.395 0.003 DBMET03077 | DBMET03077 | |
| 0.003 | 0.739 | 0.216 | Vitronectin receptor antagonist | 0.216 0.004 DBMET00552 | DBMET00552 | |
| 0.013 | 0.764 | 0.098 | Thioredoxin inhibitor | 0.098 0.05 DBMET00552 | DBMET00552 | |
| 0.002 | 0.763 | 0.2 | Integrin beta3 antagonist | 0.2 0.004 DBMET00552 | DBMET00552 | |
| 0.004 | 0.767 | 0.127 | Integrin alpha5beta1 antagonist | 0.127 0.005 DBMET00552 | DBMET00552 | |
| 0.004 | 0.771 | 0.207 | NMDA 2B receptor antagonist | 0.207 0.005 DBMET00799 | DBMET00799 | |
| 0.003 | 0.773 | 0.124 | Integrin alphaVbeta1 antagonist | 0.124 0.003 DBMET00552 | DBMET00552 | |
| 0.035 | 0.806 | 0.245 | Catenin beta inhibitor | 0.245 0.012 DBMET00552 | DBMET00552 | |
| 0.011 | 0.8 | 0.383 | Insulin secretagoues | 0.186 0.044 DBMET03075 0.383 0.007 DBMET00552 0.14 0.085 DBMET03076 0.205 0.033 DBMET03077 | DBMET00552 | |
| 0.003 | 0.794 | 0.196 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.196 0.004 DBMET00552 | DBMET00552 | |
| 0.006 | 0.799 | 0.18 | M17 leucyl aminopeptidase inhibitor | 0.18 0.04 DBMET00552 | DBMET00552 | |
| 0.003 | 0.823 | 0.588 | Integrin antagonist | 0.588 0.004 DBMET00552 | DBMET00552 | |
| 0.003 | 0.839 | 0.027 | Carnitine palmitoyltransferase 1A inhibitor | 0.027 0.022 DBMET00552 | DBMET00552 | |
| 0.002 | 0.839 | 0.416 | Prostaglandin D2 antagonist | 0.416 0.003 DBMET00552 | DBMET00552 | |
| 0.028 | 0.865 | 0.26 | Factor V inhibitor | 0.111 0.049 DBMET00552 0.26 0.003 DBMET03076 | DBMET03076 | |
| 0.036 | 0.875 | 0.195 | MAP kinase kinase 5 inhibitor | 0.172 0.081 DBMET03076 0.195 0.038 DBMET03077 | DBMET03077 | |
| 0.003 | 0.842 | 0.126 | Integrin beta5 antagonist | 0.126 0.004 DBMET00552 | DBMET00552 | |
| 0.034 | 0.874 | 0.154 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.12 DBMET03076 0.154 0.086 DBMET03077 | DBMET03077 | |
| 0.004 | 0.856 | 0.075 | Endothelin-converting enzyme inhibitor | 0.075 0.019 DBMET00552 | DBMET00552 | |
| 0.002 | 0.857 | 0.042 | Kainate receptor 3 antagonist | 0.042 0.005 DBMET00552 | DBMET00552 | |
| 0.003 | 0.866 | 0.044 | AMPA receptor agonist | 0.044 0.013 DBMET00552 | DBMET00552 | |
| 0.002 | 0.865 | 0.059 | Kainate receptor 5 antagonist | 0.059 0.005 DBMET00552 | DBMET00552 | |
| 0.004 | 0.869 | 0.072 | p53 inhibitor | 0.072 0.005 DBMET00552 0.046 0.016 DBMET03077 | DBMET00552 | |
| 0.006 | 0.877 | 0.143 | Amyloid beta precursor protein antagonist | 0.143 0.109 DBMET00552 0.135 0.12 DBMET03076 | DBMET00552 | |
| 0.002 | 0.873 | 0.046 | Kainate receptor 4 antagonist | 0.046 0.008 DBMET00552 | DBMET00552 | |
| 0.01 | 0.887 | 0.084 | Integrin alpha1beta1 antagonist | 0.084 0.003 DBMET00552 | DBMET00552 | |
| 0.005 | 0.886 | 0.442 | Cell adhesion molecule inhibitor | 0.442 0.004 DBMET00552 | DBMET00552 | |
| 0.004 | 0.892 | 0.741 | Cathepsin B inhibitor | 0.741 0.002 DBMET03076 0.072 0.027 DBMET03077 | DBMET03076 | |
| 0.003 | 0.914 | 0.1 | AMPA 2 receptor antagonist | 0.1 0.005 DBMET00552 | DBMET00552 | |
| 0.003 | 0.918 | 0.051 | Collagenase inhibitor | 0.051 0.031 DBMET00552 | DBMET00552 | |
| 0.006 | 0.936 | 0.057 | Aggrecanase 1 inhibitor | 0.057 0.01 DBMET00552 | DBMET00552 | |
| 0.002 | 0.946 | 0.556 | Cholecystokinin A agonist | 0.556 0.002 DBMET00799 | DBMET00799 | |
| 0.005 | 0.951 | 0.16 | Multidrug resistance-associated protein 1 inhibitor | 0.16 0.021 DBMET00799 | DBMET00799 | |
| 0.002 | 0.951 | 0.654 | Cholecystokinin agonist | 0.654 0.002 DBMET00799 | DBMET00799 | |
| 0.002 | 0.964 | 0.169 | Cholecystokinin antagonist | 0.169 0.005 DBMET00799 | DBMET00799 | |
| 0.007 | 0.974 | 0.062 | Carbonic anhydrase II stimulant | 0.062 0.021 DBMET00552 | DBMET00552 | |
| 0.002 | 0.97 | 0.059 | Carbonic anhydrase I stimulant | 0.059 0.012 DBMET00552 | DBMET00552 | |
| 0.002 | 0.97 | 0.152 | Cholecystokinin B antagonist | 0.152 0.004 DBMET00799 | DBMET00799 | |
| 0.001 | 0.971 | 0.017 | Carbonic anhydrase IV stimulant | 0.017 0.009 DBMET00552 | DBMET00552 | |
| 0.002 | 0.974 | 0.238 | Cholecystokinin A antagonist | 0.238 0.004 DBMET00799 | DBMET00799 | |
| 0.004 | 0.983 | 0.2 | Falcipain 2 inhibitor | 0.2 0.014 DBMET03077 | DBMET03077 | |
| 0.004 | 0.984 | 0.216 | Falcipain inhibitor | 0.216 0.012 DBMET03077 | DBMET03077 | |
| 0.001 | 0.988 | 0.029 | Cathepsin S inhibitor | 0.029 0.009 DBMET03076 0.017 0.015 DBMET03077 | DBMET03076 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |